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ABSTRACT   
 
The overall goal of this research was to design a crosslinked legume protein microcapsule 
capable of increasing viability of Bifidobacterium adolescentis when exposed to acidic 
conditions in order to maintain sufficient probiotic numbers for a host to experience a positive 
health benefit. Legume protein isolates derived from chickpea (CPI), faba bean (FPI), lentil (LPI) 
and soy (SPI) were used as wall materials to test the effect of protein-type on the protective 
nature of the capsule. The research was designed into two phases: first, the characterization of 
select physicochemical properties of legume proteins and their emulsifying properties; and 
second, the design of a genipin crosslinked capsule for carrying probiotics. 
In study 1, the physicochemical properties of legume protein isolates were investigated 
for their ability to stabilize an oil-in-water emulsion in the presence and absence of genipin. 
Solubility, surface (charge and hydrophobicity), and interfacial (interfacial tension) 
characteristics of all protein isolates were determined along with their crosslinking ability with 
genipin. Solubility was found to be highest in CPI (~94%), followed by LPI (~90%), FPI (~85%) 
and SPI (~50%). Surface characteristics of the protein isolates revealed similar zeta potentials (~ 
-47 mV) for CPI, LPI and FPI, while that of SPI was lower (~ -44 mV). In contrast, surface 
hydrophobicity was greatest for CPI (~137 arbitrary units, AU), followed by SPI/LPI (~70 AU) 
and FPI (~24 AU). A significant reduction in interfacial tension (from 16.73 to ~8.42 mN/m) 
was observed in canola oil-water mixtures in the presence of legume proteins. Genipin 
crosslinking affinity was found to be similar for each protein isolate as indicated by similar UV 
spectroscopic values. Overall, emulsion stability as determined by creaming in canola oil-water 
mixtures increased in the presence of genipin regardless of the legume protein present. 
Maximum stability in the presence of genipin was highest for SPI (65%), followed by FPI 
(61%), LPI (56%) and finally, CPI (50%).  
Based on this knowledge, all legume proteins were used as wall materials to encapsulate 
a probiotic core material. Encapsulation was performed using an emulsification technique where 
canola oil was used to form the continuous phase, and a mixture of legume protein isolate 
solutions, genipin and Bifidobacterium adolescentis was used to form the aqueous discontinuous 
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phase. Although various capsules formulation (with and without biopolymer coatings/prebiotics) 
and preparation methods (stir rates, crosslinking times) were tested, the micron sized capsules 
produced were not adequate for protecting Bifidobacterium adolescentis during acid challenge. 
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1 INTRODUCTION 
1.1 Summary 
Probiotics are live microbial organisms that impart a beneficial change to host health, 
beyond that of general nutrition, through interacting with indigenous, intestinal bacteria and/or 
by producing a metabolite (Fuller, 1989; O’Riordan et al., 2001; Picot & Lacroix, 2004). The 
health benefits associated with probiotic consumption are generally preventative in nature and 
have not been conclusively substantiated in healthy populations. However, these proposed 
benefits include: decreased lactose malabsorption; reduced risk of coronary heart disease; 
increased competitive exclusion of detrimental microbes; suppression of some cancer cells; and 
the production of certain B vitamins (Gibson & Wang, 1994a; Kulkarni & Reddy, 1994; 
Agerbaek et al., 1995; Gibson & Roberfroid, 1995; Fooks et al., 1999). In addition to having 
unproven health benefits, there are many challenges associated with probiotic supplementation. 
The first being that regardless of the probiotic used, it is widely accepted that at least 7.0 log 
colony forming units (CFU) mL
-1
 must arrive in the colon in a viable state in order for any 
benefit to be recognized by the host (Bouhnik, 1993; Krasaekoopt et al., 2003). These viable 
microbial numbers are difficult to achieve because of the natural defenses of the human 
gastrointestinal tract which have evolved to prevent invasion, colonization and subsequent 
infection by foreign bacteria. 
Encapsulation is the process by which a core material (e.g., probiotics) is entrapped 
within a wall material to afford protection from harsh environmental conditions and to help 
facilitate targeted delivery to maximize core material health benefits (Steenson et al., 1987; 
Champagne et al., 1992; Risch, 1995). Encapsulation technology has the potential to increase 
survival of probiotics within a food product and during transit through the gastrointestinal tract. 
However, findings from literature are variable depending on the wall material, the method of 
encapsulation, and the properties of the capsules themselves (Sultana et al., 2000; Truelstrup-
Hansen et al., 2002; Krasaekoopt et al., 2003). 
The overall goal in the present study was to design a crosslinked legume protein 
microcapsule for the delivery of viable Bifidobacterium adolescentis to the human colon in 
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sufficient numbers for the host to experience a positive health benefit. Specifically, 
microcapsules were prepared using proteins from chickpea, faba bean, lentils and soy, and then 
crosslinked with the non-toxic chemical fixative, genipin. Plant proteins are becoming 
increasingly important to the food industry as a replacement for animal-derived proteins (e.g., 
gelatin, casein and whey) for use as food and encapsulating ingredients. Plant proteins represent 
an attractive alternative because of their low cost, renewability and functionality, and as 
replacements for animal proteins based on consumer choices (e.g., vegans) and religious 
practices. Although soy proteins dominate the plant protein ingredient market, concerns over 
allergens are driving research activities towards other legume based proteins derived from 
chickpea, faba bean, lentil and/or pea, due to their similar physicochemical properties (Sánchez-
Vioque et al., 1999; Boye et al., 2010b; Joshi et al., 2012). Legume proteins were used for this 
study to show their applicability for use as encapsulating agents for probiotic bacteria, with the 
potential of affording improved protection against simulated gastric conditions over alginate wall 
materials. In literature, micron sized alginate capsules offer little protection to probiotics. It is 
hypothesised that the globular nature of the legume proteins will reduce pore size within the 
capsule wall to offer suitable probiotic protection. Legumes are a good source of protein that can 
be locally and inexpensively produced for use in a variety of food grade products (Comai et al., 
2007; Boye et al., 2010b). In addition to their nutritive quality, legume proteins have been 
proposed to have potential human health benefits including reducing the risk of cancer, 
cardiovascular disease, diabetes, hypertension and osteoporosis (Hu, 2003; Tharanathan & 
Mahadevamma, 2003; Boye et al., 2010b).  
 
1.2 Objectives 
To address the overall goal of this research, the following objectives were proposed: 
 to investigate the relationship between the protein’s physicochemical properties and affinity 
to genipin, with their emulsifying properties within an oil-in-water emulsion;  
 to develop genipin crosslinked microcapsules of ≤100 μm in size which are capable of 
encapsulating B. adolescentis using an emulsion-based technology; and 
 to study the survival of B. adolescentis throughout an acid challenge using various wall 
formulations (protein-type, prebiotics, and/or coating materials). 
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1.3 Hypotheses 
To address the overall goal and objectives of this research, the following hypotheses were 
proposed: 
 all legume proteins will display properties conducive to stabilizing oil-in-water emulsions, 
related to their physicochemical properties, and genipin will act to improve their ability to 
stabilize emulsions;  
 legume protein microcapsules crosslinked by genipin can be designed at sizes ≤100 μm that 
are capable of carrying a sufficient number of cells to give a health benefit to its host; and 
 legume protein capsules will afford protection to B. adolescentis during an acid challenge 
study, where survival could be enhanced in the presence of prebiotic material and/or the 
addition of coatings to the capsule’s surface. 
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2 LITERATURE REVIEW
2.1 Probiotics 
2.1.1 Definition 
 The definition of a probiotic has been modified over time as the relationship between a 
host and its intestinal microbial flora has become increasingly understood. For the purpose of 
this study, probiotics are defined as: live microbial organisms that impart a beneficial change to 
host health, beyond that of general nutrition, through interacting with indigenous bacteria and/or 
by producing a metabolite (Fuller, 1989; O’Riordan et al., 2001; Picot & Lacroix, 2004). As an 
extension of this definition a microorganism should exhibit all of the following characteristics to 
be considered an effective probiotic (Fuller, 1992; Krasaekoopt et al., 2003): 
1. retention of viability during processing on an industrial scale and during long periods 
(ideally greater than 28 days) of storage; 
2. retention of viability during passage through the gastrointestinal tract to arrive at the 
colon with numbers of at least 7.0 log CFU mL
-1
; and 
3. retention of the ability to impart a beneficial outcome upon host health. 
 
2.1.2 Health benefits 
 The health benefits associated with probiotic consumption are generally preventative in 
nature and have not been conclusively substantiated in healthy populations. Select benefits are 
thought to include: decreased lactose malabsorption; reduced risk of coronary heart disease; 
increased competitive exclusion of detrimental microbes; suppression of some cancer cells; and 
the production of certain B vitamins (Gibson & Wang, 1994a; Kulkarni & Reddy, 1994; 
Agerbaek et al., 1995; Gibson & Roberfroid, 1995; Fooks et al., 1999). Lactose malabsorption or 
intolerance has been reported to affect over half the world’s population (Fooks et al., 1999). The 
condition arises from an inadequate breakdown of ingested lactose in the human gut due to a lack 
of lactase (-galactosidase) activity. Symptoms of lactose intolerance may include abdominal 
distress and discomfort, increased flatulence, and diarrhea. Some probiotic organisms, including 
certain Lactobacillus species, can alleviate these symptoms by producing β-galactosidase in the 
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colon (Fooks et al., 1999; Montalto et al., 2006). The consumption of probiotics has been linked 
with low-density lipoprotein (LDL) and total serum cholesterol reduction, as well as LDL: high-
density lipoprotein (HDL) ratio reductions, which have been associated with reducing the risk 
and/or progression of coronary heart disease (Levy et al., 1984; Gordon et al., 1989; Schaafsma 
et al., 1998). The potential mechanisms proposed for this probiotic action include: interference 
with cholesterol absorption in the gut, direct uptake of cholesterol by probiotics, and production 
of metabolites that could impact total blood lipid levels in the host (Fooks et al., 1999). 
Probiotics may also reduce the number of pathogenic organisms present in the gut through 
competitive exclusion, which may decrease the frequency of intestinal infections, largely through 
competition for nutrients. There are approximately 10
12
 live cells per gram of human large 
intestinal contents, making access to nutrients very competitive, which is the main mechanism by 
which one type of microbe may reduce the population of another (Gibson & Wang, 1994a). 
Consumption of probiotics has been identified as having potential as a preventative measure for 
colon cancer which is one of the leading causes of death in the USA (Benno & Mitsuoka, 1992; 
Kulkarni & Reddy, 1994). Proposed mechanisms of action include: suppression of carcinogens 
by blocking, binding or removal; competitive suppression of enzyme producing microbes that 
have the potential to convert procarcinogens to carcinogens; and a reduction in gastrointestinal 
transit time which limits exposure to potentially harmful compounds (Fooks et al., 1999). 
Finally, some Bifidobacterium species have the ability to produce water soluble B vitamins 
including thiamine, nicotinic acid, folic acid, vitamin B12 and biotin, which can impart the host 
with nutritional benefits beyond those implicit to the organism itself (Deguchi et al., 1985; Noda 
et al., 1994). 
 
2.1.3 Types and sources 
 Many bacterial organisms have the potential to be used as probiotics, but traditionally 
three genera have been utilized with the greatest frequency: Bifidobacterium, Lactobacillus and 
Streptococcus. Bifidobacteria are Gram positive microaerophilic branch-shaped rods that can 
account for approximately 95% of colonic organisms in infants (Yoshiota et al., 1991; Gibson & 
Roberfroid, 1995). Although this number generally drops to 25% in adults, they are an important 
segment of human gut flora and have been associated with many probiotic health benefits 
(Fuller, 1992; Gibson & Roberfroid, 1995; Gibson et al., 1997). Many Lactobacillus species, 
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which are non-sporulating anaerobic Gram positive rod-shaped bacteria, are used as probiotics as 
they can survive and grow in a number of acidic fermented foods (e.g., yogurt), are well suited 
for growth in the human colon, and have β-galactosidase activity (Fuller, 1992; Fooks et al., 
1999). Also, some Streptococcus species (e.g., S. thermophilus) of human oral and nasal origin 
have been identified as probiotics as they meet the aforementioned definition (Salminen et al., 
1998). These bacteria are facultative anaerobic Gram positive coccoids that are usually found in 
pairs or chains (Fuller, 1992; Fooks et al., 1999). The aforementioned probiotics can be found in 
many food products and supplements, and may act as starter cultures in food products that 
employ microbial fermentation.  
 
2.1.4 Challenges of probiotic use 
 There are many challenges associated with probiotic supplementation. The first being that 
regardless of the probiotic used, it is widely accepted that at least 7.0 log CFU mL
-1
 must arrive 
in the colon in a viable state in order for any benefit to be recognized by the host (Bouhnik, 
1993; Krasaekoopt et al., 2003). These viable microbial numbers are difficult to achieve because 
the natural defenses of the human gastrointestinal tract have evolved to prevent invasion, 
colonization and subsequent infection by foreign bacteria. Primarily, low stomach pH results in a 
decrease in viable probiotic counts between ingestion and ensuing arrival at the colon, however 
the presence of bile salts and proteases also play a role (Marteau et al., 1997; Lee & Heo, 2000; 
Truelstrup-Hansen et al., 2002; Picot & Lacroix, 2004). As an example, Truelstrup-Hansen et al. 
(2002) reported that B. breve 15700 and B. longum 15707 populations exposed to pH 2.0 at 37°C 
for 2 h were reduced by 3.6 and 4.6 log CFU mL
-1
 respectively as compared to controls at pH 
6.0. In contrast, after 30 min exposure at pH 1.9, in the presence of pepsin, B. breve R070 and B. 
longum R023 populations with initial inoculation levels of approximately 8.0 log CFU mL
-1
, 
were reduced by approximately 6.0 and >7.0 log CFU mL
-1
 respectively (Picot & Lacroix, 2004).  
Fuller (1989) reported that peristalsis resulted in the flushing of invading bacteria out with food 
to act as another hurdle to colonization of the gut. In another instance, Marteau et al. (1997) 
demonstrated that viable counts after 110 min in the gastric compartment (pH decrease from 5.0 
to 1.8 by 80 min; in the presence of electrolytic salts and pepsinogen (370 U mL
-1
)) of a dynamic 
GIT model were reduced from initial inoculation levels (7.0 – 8.0 log CFU mL-1) to: less than 
1% for S. thermophiles and L. bulgaricus, 60% for L. acidophilus and 80% for B. bifidum. 
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Probiotic numbers and viability in foods may also decrease during processing, which can include 
freeze and/or spray drying, heating/cooling and during storage (Mattila-Sandhlm et al., 2002).  
The inability of a single bacterial strain to exhibit and optimize all of the ideal 
characteristics of a probiotic is another limitation of these microorganisms (Sanders & Marco, 
2010). A single strain probiotic is ideal in simplifying production, proving efficacy, identifying 
relationships with native host flora and elucidating mechanisms of action. However, with current 
probiotics, some organisms exhibit better survival characteristics while others have a wider 
spectrum of proposed probiotic impact. Therefore, because there is no perfect probiotic 
organism, researchers are obliged to maintain realistic expectations regarding the probiotic 
strains that are currently available, and develop other means to optimize their efficacy.  
 A lack of concrete evidence regarding the efficacy of probiotic supplementation in 
humans with respect to measurable health benefits also impacts this field’s acceptance and 
opportunities. The majority of peer-reviewed probiotic human trials involve subjects with an 
illness of some kind which has led to a lack of conclusive evidence regarding the effect of 
probiotics on healthy individuals. Although not fully proven, an intestinal flora shift from 
unhealthy to healthy is the currently accepted general probiotic mechanism. However, healthy 
humans carry a wide variety of intestinal flora which displays little similarity between 
individuals or within one individual through time (Turnbaugh et al., 2009; Lyra et al., 2010; 
Salonen et al., 2010). Therefore, it has not been conclusively proven that probiotics will have a 
beneficial impact for an individual with a healthy compliment of microbial flora, or an ability to 
generate a healthy flora profile (which is not characterized and may vary). This is mainly due to 
insufficient resolution of human intestinal populations, even when utilizing advanced molecular 
techniques. It has been shown that even when a shift in intestinal flora population caused by 
probiotics has been demonstrated, the effect was temporary, with no lasting impact (Lyra et al., 
2010; Salonen et al., 2010). Human testing is further complicated as any quantitative or 
qualitative health increases associated with probiotics may be a factor of a variety of healthy 
lifestyle choices such as diet and exercise. This becomes a circular problem because ethically 
there is a requirement for evidence of efficacy in the complex microbial environment of a 
healthy human prior to widespread trials and testing. The current state of flux in international 
labeling laws and regulations regarding probiotics may also be doing irreparable damage to the 
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field, as the current market is flooded with unproven and possibly ineffective products (Sanders 
& Marco, 2010). 
 
2.2 Prebiotics 
2.2.1 Definition 
 Similar to probiotics, the definition of prebiotics has been refined over time to reflect 
increased understanding of their role in human gut health. The definition of prebiotics used for 
this study is: “Indigestible dietary components that pass through the digestive tract to the colon 
and selectively stimulate the proliferation and/or activity of one, or a limited number, of 
desirable bacteria (probiotics) in the colon resulting in increased host health” (Gibson & Wang, 
1994b; Crittenden, 2001). An important aspect of prebiotics is that they only impact bacteria 
already present in the colon; they are not microbes themselves with the capacity to change or add 
to the composition of the native gut flora. As part of the above definition prebiotics must meet 
the following criteria (Gibson & Roberfroid, 1995): 
1. they cannot be hydrolyzed or absorbed in the upper part of the human digestive system; 
2. they must cause growth and/or activation of one or a limited number of beneficial colonic 
bacteria by being a selective substrate; and 
3. they must be able to change the microflora of the colon to a healthier composition and as 
a result induce beneficial luminal or systemic effects to the health of the host. 
 
2.2.2 Health benefits 
 Prebiotics have the same potential associated health benefits and mechanisms of action as 
probiotics because these microorganisms metabolize and/or are activated by prebiotics so as to 
provide beneficial luminal or systemic effects to the host. These effects may include: decreasing 
the number of detrimental bacteria present in the colon; reducing plasma lipid levels to reduce 
the risk of coronary heart disease; production of some B vitamins; and providing constipation 
relief to the host (Delzenne & Roberfroid, 1994; Tomomatsu, 1994; Fiordaliso et al., 1995; 
Gibson & Roberfroid, 1995; Gibson et al., 1995). In addition to increasing the effect of 
probiotics, some animal studies have shown that certain prebiotics have increased the intestinal 
concentration and absorption of ions, including Ca
2+
 and Fe
2+
 (Levrat et al., 1991; Delzenne & 
Roberfroid, 1994). The mechanism for this effect has not been elucidated but is proposed to 
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relate to modified osmotic conditions within the large intestine which may impact absorption 
(Levrat et al., 1991). A significant limitation of prebiotics is that a pathogen may develop a 
mechanism to utilize a known prebiotic so as to increase its own proliferation and cause harm to 
the host (Rastall, 2010). This could, in the future, preclude the use of some compounds which 
otherwise could be prebiotics. 
 
2.2.3 Types and sources 
 As defined, prebiotics are generally classed as non-digestible carbohydrates 
(oligosaccharides); however some peptides, proteins and lipids can also be classified as 
prebiotics (Gibson & Roberfroid, 1995). This review will focus on carbohydrate prebiotics, 
specifically oligosaccharides, as they are the most thoroughly studied in literature. 
Oligosaccharides are characterised as molecules of 2-9 covalently linked monosaccharides 
(Roberfroid, 2000) that are water soluble, have a low caloric impact, and exhibit a low sweetness 
value (0.3 to 0.6) (Crittenden & Playne, 1996). 
 A commonly studied group of prebiotics are fructooligosaccharides (FOS), which are 
characterized by their β-(12) glycosidic bonded β-D-fructose moieties which may contain a 
terminal D-glucose α-(12) linkage (Roberfroid, 2000). FOS are usually produced through 
inulin hydrolysis (acid or enzyme mediated) and these prebiotics have been shown to increase 
the growth rate of some Bifidobacterium species to a greater extent than native inulin (Gibson & 
Wang, 1994b; Bielecka et al., 2002; Rossi et al., 2005). Other oligosaccharides that have been 
shown to support the growth of probiotics include: galactooligosaccharides (Vernazza et al., 
2006), maltooligosaccharides (Crittenden & Playne, 1996), and xylooligosaccharides (Rastall, 
2010).  
 
2.3 Microencapsulation 
 Microencapsulation is the process of entrapping a core material within a wall matrix so as 
to form a capsule with a diameter between 0.2 and 5000 μm. The wall matrix provides protection 
of the core material from harsh environmental conditions and may also facilitate targeted 
delivery of bioactive ingredients (e.g., probiotics) (Steenson et al., 1987; Champagne et al., 1992; 
Risch, 1995). Depending of the type of wall matrix used, the encapsulated core material can be a 
solid, liquid or gas, and can be hydrophilic or hydrophobic. In this research, the core material 
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used was the acid sensitive probiotic, B. adolescentis, which requires protection from the harsh 
conditions of the stomach. The two major methods of microcapsule formation for bioactive 
ingredients such as probiotics are based on extrusion and emulsion technologies. These two 
methods are amenable to a wide variety of wall materials so as to provide diverse 
physicochemical properties that impact the functionality of the microcapsule. 
 
2.3.1 Extrusion technique for encapsulation 
 The first and oldest method of encapsulation is extrusion, which generally involves the 
use of hydrocolloids such as alginate as wall materials in conjunction with ionic crosslinking 
(Tanaka et al., 1984; Risch, 1995). This encapsulation method is simple, inexpensive, and gentle 
which generally provides high retention of core materials (Risch, 1995). Wall materials including 
alginate (Risch, 1995; Krasaekoopt et al., 2003), and whey protein isolates (Picot & Lacroix, 
2004; Hebrard et al., 2010) can be used for capsule formation. The main limitations of extrusion 
based technology are that the capsules formed are too large (2-5 mm) to be used in a food 
product without negatively impacting its textural and mouth-feel characteristics, and the 
procedure is difficult to efficiently scale up (Truelstrup-Hansen et al., 2002; Krasaekoopt et al., 
2003). In this method, the wall and core (bioactive) materials are mixed together in a 
hydrocolloid solution. As this solution is extruded through a syringe, droplets fall into an ionic 
solution (e.g., Ca
2+
 in the form of CaCl2) which serves to set and crosslink the hydrocolloid 
solution into a stable capsule with a three-dimensional lattice structure (Risch, 1995; 
Krasaekoopt et al., 2003). The size of the resulting capsules is mainly dependant on the gauge of 
syringe used, although the wall and core material concentration, ionic solution viscosity and 
distance between the syringe tip and the ionic solution can also have an impact.  
Extrusion technology has been successfully used for the encapsulation of probiotics. For 
instance, Chandramouli et al. (2004) prepared an alginate (1.8%) capsule (~450 μm in diameter), 
hardened for 30 min in 0.1M CaCl2, containing L. acidophilus (initial counts of 9.0 log CFU   
mL
-1
) and subjected it to an acid challenge for 3 h at 37
o
C. The authors reported a protective 
effect of the wall material where only a ~1.0 and ~2.0 log reduction occurred at pH 3.0 and 2.0, 
respectively. Lee & Heo (2000) also reported that the encapsulation of Bifidobacterium species 
(initial counts of 7.0 log CFU capsule
-1
) within an alginate (4.0%) capsule (~2.6 mm in diameter) 
that resulted in only a ~1.0 log reduction during a challenge study at pH ~1.5 (with 0.2% NaCl) 
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for 3 h at 37
o
C. In addition, Reid et al. (2005) prepared whey protein (12%) capsules (~2.8 mm 
in diameter) to entrap Lactobacillus rhamnosus at levels of 6.2 log CFU mL
-1
. When exposed to 
dynamic simulated gastric conditions (pH decrease from 4.4 to 2.0 over 90 min) encapsulated 
cells exhibited a
 
2.4 log CFU mL
-1
 reduction compared to a ~4 log CFU mL
-1
 reduction for free 
cells. 
The extrusion-based method was not considered as a means for encapsulation within the 
current thesis due to challenges associated with obtaining capsule sizes <100µm.  
 
2.3.2 Emulsification technique for encapsulation 
 Encapsulation of probiotic bacteria using an emulsification procedure has also been 
established in literature (Sheu & Marshall, 1993; Sultana et al. 2000; Truelstrup-Hansen et al., 
2002; Winder et al., 2003). This process is advantageous relative to extrusion-based capsule 
production, because micron-sized capsules are produced; the simplicity of the methodology; the 
reduced amount of wall material required; and the ease of scale up (Winder et al., 2003). 
However, despite these advantages, the microcapsules produced tend to offer poor protection 
(reduced survival) to probiotics, have decreased core loading capacity and have a large size 
distribution (0.025 – 2 mm) (Truelstrup-Hansen et al., 2002). The technique involves the 
formation of a water-in-oil emulsion upon application of mechanical shear to form micron sized 
droplets. In this case, the continuous phase typically consists of vegetable oil (e.g., canola or 
corn), and the discontinuous phase consists of both the wall and core materials (Krasaekoopt et 
al., 2003). However, the method is flexible and the phases can be reversed as required for a 
hydrophobic core material. Surfactants may also be added to formulations at various 
concentrations (e.g., Tween 80: 0.33–1.00 g/g [Devi & Maji, 2010] or 0.02% g/g [Sultana et al., 
2000] of wall material polymer) to help increase uniformity in droplet size distribution. The 
addition of an ionic (e.g., Ca
2+
) or enzymatic crosslinking agent (e.g., transglutaminase) also acts 
to stabilize individual droplets by inducing gelation/crosslinking of the wall materials to form 
capsules, which can then be separated and harvested (Sultana et al., 2000; Truelstrup-Hansen et 
al., 2002; Krasaekoopt et al., 2003; Winder et al., 2003). 
The size of formed microcapsules is primarily related to the level of mechanical shear 
prior to inducing droplet gelation; however both the wall material concentration and the 
viscosities of continuous and discontinuous phases play a secondary role in size (Truelstrup-
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Hansen et al., 2002; Krasaekoopt et al., 2003). Capsules <100 µm in diameter are typically 
desired as at this size negative impacts to textural attributes and mouth feel characteristics, upon 
their addition to foods, do not occur (Krasaekoopt et al., 2003; Picot & Lacroix, 2003). However, 
challenges associated with the high surface area-to-volume ratios of these small-sized capsules 
have led to poor probiotic protection under both simulated gastric and acid challenge 
experiments (Sultana et al., 2000). Surfactant and wall material concentrations within capsule 
formulations have also been investigated for their effects on capsule size, where overall, 
increased surfactant load and decreased wall material concentration (lower viscosity) lead to 
decreases in capsule sizes. Surfactants act to lower the interfacial tension between phases of the 
emulsion, which enables smaller droplets to form upon shearing, and coating of the surface of 
the droplets so as to create a physical barrier (Zhuo et al., 2004; Devi & Maji, 2010). 
Sultana et al. (2000) utilized a wall material comprised of alginate (2%) and Hi-maze 
resistant starch (2%), hardened with the addition of 0.1M CaCl2, to encapsulate Lactobacillus 
acidophilus and Bifidobacterium species using an emulsification technique in oil. The authors 
reported capsule size ranges between 500 to 1000 µm, with only a small proportion of sizes <500 
μm. Acid challenge studies (pH 2.0 for 3 h) involving the capsule designs indicated a 5 and 3 log 
CFU mL
-1
 reduction for entrapped L. acidophilus and B. infantis, respectively. In contrast, 
Truelstrup-Hansen et al. (2002) produced Ca
2+
-alginate capsules (20 g L
-1
 alginate, 5 g L
-1
 
Tween 80, 62.5 mM CaCl2) containing four strains of Bifidobacterium (adolescentis 15703, 
breve 15700, lactis Bb-12 and longum Bb-46) at levels ranging from 6-8 log CFU mL
-1
. This 
methodology produced capsule sizes of ~70 μm, however during an acid challenge (pH 2.0, 30 
min), a 5 log CFU mL
-1
 reduction for all strains was observed, with the exception of B. lactis 
which remained constant. Annan et al. (2008) reported that an emulsion produced, genipin 
crosslinked gelatin microcapsule, with an alginate coating, was able to protect encapsulated B. 
adolescentis. When subjected to sequential simulated gastric juice (SGJ) and simulated intestinal 
fluid (SIF) treatments (to simulate the human gastrointestinal tract) these capsules exhibited only 
a 1.21 log CFU mL
-1
 reduction in viable numbers in SGJ, and released 7.35 to 7.57 log CFU  
mL
-1
 of viable probiotics in SIF. In addition, Borza et al (2010) reported that emulsion-produced 
gelatin (16%)-maltodextrin (3%) composite microcapsules crosslinked with genipin (24 mM), 
having a size of ~70 μm were able to protect encapsulated B. adolescentis from SGJ (pH 2.0; 
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0.32 mg mL
-1
 pepsin). After 2 h of exposure to SGJ free cells experienced a ~4 log CFU mL
-1
 
reduction in numbers while encapsulated cells experienced only a ~2 log CFU mL
-1
 reduction.  
 
2.4 Wall materials 
 The wall materials used in the formation of microcapsules play an important role in terms 
of the protection afforded, the type of bioactive ingredient that can be encapsulated and the 
desired core release profiles in terms of dosage and release rates. Materials should be food grade, 
and exhibit both emulsifying and gelling properties in the presence of ionic or covalent 
crosslinkers. Prepared capsules should also be miscible within food products, offer protection to 
the core ingredient within the food environment and the harsh acidic conditions of the stomach 
(Hebrard et al., 2010). Typically, microcapsules for carrying probiotics are prepared using either 
proteins or polysaccharides, alone or in combination. Examples of hydrocolloid wall materials 
include but are not limited to: alginate, carrageenan, cellulose acetate phthalate, chitosan, gelatin, 
low methoxy pectins and whey protein isolates (Risch, 1995; Roberfroid, 2000; Krasaekoopt et 
al., 2004; Anal & Singh, 2007; Hebrard et al., 2010). To afford additional protection to the 
encapsulated probiotic bacteria, wall materials can be used in combination, and/or coatings can 
be added using biopolymers with opposing charges to the main capsule wall. For example, the 
positively charged chitosan (or poly-L-lysine) could be used to coat capsules prepared from 
negatively charged alginate (Lee & Heo, 2000; Corcoran et al., 2003; Hebrard et al., 2010).  
 Alginate is a common wall material used for the encapsulation of probiotics because of 
its low cost and gelling abilities in the presence of calcium ions. Alginate-based capsules have 
been prepared both by extrusion (Lee & Heo, 2000; Chandramouli et al., 2004) and 
emulsification (Sultana et al., 2000; Truelstrup-Hansen et al., 2002) based techniques. Alginate is 
a linear polysaccharide that is extracted from various brown algae species and is comprised of 
repeating α-L-guluronic acid and β-D-mannuronic acid monomeric units. Alginate may be 
comprised of homopolymeric blocks of either monomer or heteropolymeric blocks of both 
monomers randomly arranged within the same molecule (Boguń & Rabiej, 2010). The ratio of 
these monomers can change the physicochemical properties of this material from a dense but 
brittle gel if α-L-guluronic acid is the more dominant monomer, to a softer and more elastic gel if 
β-D-mannuronic is the major monomer unit. Chandramouli et al. (2004) prepared alginate 
(1.8%) capsules (~450 μm in diameter), hardened for 30 min in 0.1M CaCl2, containing L. 
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acidophilus (initial counts of 9.0 log CFU mL
-1
) and subjected them to an acid challenge for 3 h 
at 37
o
C. The authors reported a protective effect of the wall material where a ~1.0 and ~2.0 log 
reduction occurred at pH 3.0 and 2.0, respectively. Lee & Heo (2000) also reported that the 
encapsulation of Bifidobacterium species (initial counts of 7.0 log CFU capsule
-1
) within an 
alginate (4.0%) capsule (~2.6 mm in diameter) resulted in a ~1.0 log reduction during a 
challenge study at pH ~1.5 for 3 h at 37
o
C. Truelstrup-Hansen et al. (2002) produced Ca
2+
-
alginate capsules containing four strains of Bifidobacterium at levels ranging from 6-8 log CFU 
mL
-1
. This methodology produced capsule sizes of ~70 μm, however during an acid challenge 
(pH 2.0, 30 min), a 5 log CFU mL
-1
 reduction for all strains was observed, with the exception of 
B. lactis which remained constant. This reduction in probiotic viability was proposed to be 
primarily a factor of capsule size and the resultant high surface area to volume ratio. 
Protein isolates have been utilized as capsule wall materials, particularly whey protein 
isolate (WPI) because of cost, availability, safety and amphiphilic nature (Charteris et al., 1998; 
Reid et al., 2005; Hebrard et al., 2010). These characteristics of WPI, along with its emulsifier 
activity, make it a useful wall material in encapsulation studies. WPI consists of β-lactoglobulin 
(58 % of total protein content; 18.3 kDa), α-lactalbumin (14.1 kDa), serum albumin, 
immunoglobulins and protease peptones. Gel formation occurs when the protein is heated to 
induce denaturation and polymerization, followed by cooling and the addition of CaCl2 
(Hongsprabhas & Barbut, 1997; Bryant & McClements, 2000). Reid et al. (2005) reported that 
whey protein capsules (12%) extruded into a CaCl2 crosslinking solution (to produce capsules of 
~2.8 mm diameter) were able to encapsulate Lactobacillus rhamnosus at levels of 6.2 log CFU 
mL
-1
, and afforded better protection during a 90 min SGJ challenge experiment, where viable 
cell counts were reduced by only 2.4 vs. a ~4.0 log reduction for free cells. 
  
2.4.1 Legume protein wall materials 
Chickpea, faba bean, lentil and soy proteins have been shown to have similar physical 
properties. Iqbal et al. (2006) found that the crude protein levels were 24.0%, 26.1% and 24.9% 
for chickpea, green lentil and green pea, respectively. Boye et al. (2010b) reported that legume 
seeds from chickpea, faba bean, soy and lentil present a good source of nutritious proteins. 
Legumes are dominated by two major classes of proteins: albumins and globulins. The former 
are water soluble with molecular masses ranging from 5 – 80 kDa. Globulins are salt soluble 
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proteins consisting of legumin (11S (Sevdberg Unit), hexameric, ~350-400 kDa) and vicilin (7S, 
trimeric, ~50-60 kDa) (Boye et al., 2010b). Legume proteins display relatively high solubility 
(>80%) at pH 7.0 (depending on the method of extraction/processing), with isoelectric points 
ranging between 4.0 and 5.0 (Boye et al., 2010b). The applicability of legume proteins as wall 
materials for carrying probiotics is limited in the literature. As an example, Klemmer et al. 
(2011) reported that capsules (~2 mm in diameter) made with pea protein-alginate mixtures via 
extrusion were able to protect encapsulated B. adolescentis from SGJ (pH 2.0) over 2 h at levels 
of 8.0 log CFU mL
-1
,while free cells were reduced below detectable limits after only 30 min. 
 
2.4.1.1 Chickpea 
Although a number of varieties of chickpea (Cicer arietinum) exist, the two major ones 
grown for commercial production are Kabuli and Desi. Chickpea acreage increased dramatically 
in Saskatchewan between 1996 and 2005 from 6,000-172,000 acres and production peaked in 
2001 with 1.1 million acres. In 2011, Saskatchewan produced an estimated 75,200 tonnes of 
chickpeas with average production of 133,200 tonnes from 2001-2010 (Saskatchewan Ministry 
of Agriculture, 2011). Over the past several years India has produced and consumed 
approximately 4-6 million tonnes of the total world chickpea production of 7-9 million tonnes 
(McVicar et al., 2007). Chickpea protein levels have been reported to range from ~20-25%, with 
globulins representing the largest total protein fraction (~42%) (Sánchez-Vioque et al., 1999; 
McVicar et al., 2007; Boye et al., 2010b). Some important amino acid contents of chickpea seeds 
include lysine (1.29-1.37%), methionine (0.26-0.31%), and threonine (0.66-0.73%) (McVicar et 
al., 2007). Sánchez-Vioque et al. (1999) produced a chickpea protein isolate by isoelectric 
precipitation which was found to have a protein content of ~78%, a pI value of 4.3 and protein 
solubility >80% at pH 6.5. Physicochemical analysis of this isolate revealed water absorption, fat 
absorption and emulsion capacity values, per 100 g of isolate, of ~343 g, ~409 g and ~48% 
(w/w) respectively. In vitro chickpea protein digestibility was shown to be ~76% due to the 
largely globular structure of the protein which limits hydrolysis by digestive enzymes (Sánchez-
Vioque et al., 1999).   
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2.4.1.2 Faba bean 
 Faba beans (Vicia faba), belonging to the ‘dry/broad bean family’, are consumed as both 
whole foods and as ingredients worldwide, and were first grown in western Canada in 1972 
(McVicar et al., 2008). World production and import/export data for faba bean has not been 
compiled, however dry broad bean production ranged from 4.9-5.1 million tonnes from 2003-
2006, where China accounted for almost half of all production (McVicar et al., 2008). Faba bean 
seeds contain 24-30% protein and have cysteine, lysine and methionine contents of 0.25-0.31%, 
1.48-1.61% and 0.17-0.19% respectively (McVicar et al., 2008). Faba bean protein is comprised 
of 10-30% albumins and 45-78% globulins (El Fiel et al. 2002; Boye et al., 2010b). Faba bean 
protein solubility in water values of >95% have been reported. Based on literature review there is 
very little physicochemical data available on faba bean protein. 
 
2.4.1.3 Lentil 
Lentils (Lens culinaris) are one of the most economically important members of the 
legume family and Canada is the leading exporting nation of lentils. Production in western 
Canada began in 1970 with 600 hectares (ha) and increased to 960,000 ha by 2009 (McVicar et 
al., 2010). In 2011, an estimated 1,455,000 tonnes of lentils were grown in Saskatchewan and a 
yearly average of 920,200 tonnes were produced from 2001-2010 (Saskatchewan Ministry of 
Agriculture, 2011). World production of lentils ranged from 2.8-4.0 million tonnes from 2000-
2007 with India being the largest producing and consuming nation (McVicar et al., 2010). Lentil 
is used mainly for human consumption as a protein source, and its seeds have a crude protein 
content of ~19-26%. Lentils are very high in globulins at approximately 70% of the total protein 
content (Iqbal et al., 2006; Boye et al., 2010a; McVicar et al., 2010). Lentil protein isolates in 
particular have been studied as an alternative to soy protein isolates in both food products and 
encapsulation formulations because of their interfacial and emulsifying properties (Joshi et al., 
2012). Joshi et al. (2012) produced a lentil protein isolate by isoelectric precipitation with a final 
protein content of ~90% and subsequently compared its physicochemical, interfacial and 
emulsifying properties to a whey protein isolate (WPI) and sodium caseinate (NaCas). The effect 
of emulsifier concentration, pH and temperature were all evaluated on properties including, but 
not limited to: interfacial tension, emulsion stability index, zeta potential and surface 
hydrophobicity. It was reported that a lentil protein isolate can be equally effective as WPI and 
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NaCas, as an emulsifier, at levels ≥ 20 mg mL-1 (Joshi et al., 2012). These results indicate the 
potential for lentil proteins to be used as a wall material for encapsulation (Reid et al., 2005). 
 
2.4.1.4 Soy 
 Soybean (Glycine max) is an oilseed crop, but because of its high crude protein content (> 
35%) it is also used in a variety of food products including soy milk and tofu (Canadian Grain 
Commission, 2011). From 2006-2010 the average protein content of soybeans grown in Canada 
was 40.0% and in 2011 4.2 million tonnes of soybeans were harvested (primarily in Ontario, 
Manitoba and Quebec) (Canadian Grain Commission, 2011). Soy protein is made up primarily of 
globulin (11S) subunits, but also contains 7S, 15S and 2S subunits in decreasing amounts 
(Kinsella, 1979; Friedman & Brandon, 2001). Soy protein is one of the most thoroughly studied 
and economically important plant proteins in terms of its functional properties and its potential to 
behave as an animal protein alternative (Friedman & Brandon, 2001; Joshi et al., 2012). As a 
result it is also one of the few plant proteins available for purchase as a protein isolate. As an 
example, Okezie & Bello (1988) reported that an industrially produced SPI (97% protein) had an 
emulsion capacity of 8 mL of oil g
-1
 of protein and water and oil adsorption values of 4.10 and 
4.88 g/g of protein respectively. Select amino acid contents were also reported as 6.1% lysine, 
3.7% threonine and 1.4% tryptophan. Other legume proteins continue to be studied as a soy 
alternative in part because of the potential for different functional properties and the designation 
of soybean as one of eight priority allergens in Canada, the USA and the EU (Friedman & 
Brandon, 2001; Boye et al., 2010b). 
 
2.5 Crosslinking of proteins 
 The crosslinking of protein wall materials during the encapsulation process provides 
additional structural integrity, improved bioactive ingredient protection, and may aid in the 
targeted delivery of bioactives. There are a variety of compounds (chemical reagents and 
enzymes) and analytical protocols that can be used to induce protein crosslinking, however many 
of the chemical reagents exhibit significant toxicity and are not approved for food use. For 
instance, epoxides, formaldehyde and glutaraldehyde are effective crosslinking agents but are 
cytotoxic (Butler et al., 2003; Nickerson et al., 2006b). Protein crosslinking can also be achieved 
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by using enzymes such as laccase, transglutaminase and tyrosinase, however only bacterial 
transglutaminase is considered food grade and commercially available (Buchert et al., 2010).  
 For this research, a novel chemical crosslinking agent, known as genipin, was used to 
crosslink the legume proteins during capsule formation. This chemical compound has been 
approved for pharmaceutical and food-grade use (e.g., as a pigment) in Japan, Korea and Taiwan 
(Sung et al., 1999; Mi et al., 2000; Paik et al., 2001; Nickerson et al., 2006c), but has not yet 
received approval in Canada. Gardenia jasminoides fruits, which contain the genipin precursor 
geniposide, have been used in traditional Chinese medicine for their anti-inflammatory, diuretic 
and haemostatic properties (Mi et al., 2000; Butler et al., 2003; Jin et al., 2004). In addition, a 
related variety of this plant, Genipa Americana, is found in Mexico, the Caribbean and Argentina 
where its fruits are commonly eaten raw and used to make a sour beverage (Butler et al., 2003).  
 
2.5.1 Genipin 
Genipin is a crosslinking agent obtained from the Gardenia fruit via enzymatic 
hydrolysis from its parent compound, geniposide, by β-glucosidase (Butler et al., 2003; 
Nickerson et al., 2006b). The structure of genipin was elucidated by Djerassi et al. in 1961 
(Figure 2.1). Gels crosslinked by genipin exhibit comparable strength to those crosslinked by 
glutaraldehyde (Nickerson et al., 2006b), but have been reported to be much less cytotoxic 
(5000-10,000 times) (Sung et al., 1999; Mi et al., 2000; Jin et al., 2004). Genipin has been used 
to crosslink a variety of materials including but not limited to: bovine serum albumin (BSA), 
chitosan, gelatin, gelatin-carrageenan mixtures, soy and whey proteins (Butler et al., 2003; 
Annan et al., 2008; Huang et al., 2009; Devi & Maji, 2010). Genipin is known to form intra- and 
intermolecular covalent bonds through reactions principally with the primary amines of lysine, 
but also with those in hydroxylysine and arginine residues (Fujikawa et al., 1988; Butler et al., 
2003; Nickerson et al., 2006a,b; Maji & Hussain, 2008). One limitation to the utility of genipin 
as a crosslinking agent is that the reaction takes 3 to 4 h to complete and is pH dependant (Maji 
& Hussain, 2008). The proposed mechanism for this reaction involves the following two steps 
(Figure 2.2): (1) a nucleophilic substitution to the dihydropyran ring of genipin followed by a 
Schiff’s base reaction; and (2) a separate Schiff’s base reaction with the ester group of the 
genipin molecule. For both reactions, the primary amine group, provided by a protein is required 
for crosslinking with genipin (Butler et al. 2003). The first reaction is initiated by nucleophilic 
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attack at C3 of genipin by a primary amine group on the protein that results in dihydropyran ring 
opening and formation of an aldehyde group and a secondary amine. The ring then closes as the 
secondary amine reacts with the aldehyde group, to form a heterocyclic ring bound to a protein 
molecule (Butler et al., 2003). The second reaction is a SN2 nucleophilic attack at the ester group 
on the genipin molecule by a separate primary amine so as to produce an amide linkage. The 
evidence for these two reaction mechanisms was based on 
13
C nuclear magnetic resonance 
(NMR), infrared spectroscopy (IR) and rheological data collected during genipin crosslinking 
experiments with chitosan, BSA, gelatin and glucosamine (Butler et al. 2003). In brief, the 
authors found that the 
13
C NMR chemical shifts of the genipin ester group did not change during 
the initial stages of the reaction and the storage modulus did not change until traces of methanol, 
used to measure this SN2 reaction, were detected; indicating that amide formation was the second 
reaction in the crosslinking mechanism. Also, the IR bands for C-N increased upon initial 
reaction of genipin with the aforementioned polymers at the expense of the IR bands for C-O, 
indicating the ring opening reaction occurred first. Finally, 
13
C NMR and spectrophotometric 
data associated with the immediate formation of the heterocyclic genipin-chitosan compound 
provided additional evidence for this reaction mechanism (Butler et al., 2003). The authors 
postulated that the slow rate observed for the second reaction was due to an acid catalysis 
requirement that is only provided after the first reaction reaches completion.  
 
 
 
 
Figure 2.1 Chemical structure of genipin  (Feng et al., 2011). 
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Figure 2.2 Proposed crosslinking reaction mechanism of genipin with primary amines 
(adapted from Butler et al., 2003) 
 
During genipin crosslinking of proteins/chitosan a blue colour forms. The formation of 
this colour is associated with oxygen radical induced polymerization of the genipin molecule, 
which is proposed to only occur following the ring opening step in the first reaction. 
Polymerization of the genipin molecule also allows it to be sufficiently flexible so as to interact 
with different protein molecules to form intermolecular crosslinks without high levels of steric 
hindrance (Butler et al., 2003). A range of environmental conditions, such as temperature and 
pH, under which the crosslinking reaction takes place, may also impact the degree of intra- and 
intermolecular crosslinking that is possible due to changes in protein conformation, which may 
alter the number of available primary amine sites. Protein structure can also impact the degree of 
crosslinking. For example, globular proteins are generally less available for crosslinking because 
their compact secondary and tertiary structures limit physical access of the genipin molecule 
(Buchert et al., 2010). The conformation of the wall materials during capsule formation and 
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subsequent crosslinking is very important and may be controlled by the reaction conditions 
utilized. For example, complete or partial denaturation of a reactant protein (via pH, heat 
treatment, etc.) can modify its crosslinking activity with genipin and impact capsule formation 
(Meena et al., 2008; Buchert et al., 2010). 
 
 2.5.2 Effects of genipin crosslinking 
It has been shown that although microcapsules produced via crosslinking have decreased 
core material concentrations per capsule, they exhibit increased acid resistance to the harsh 
stomach environment (Annan et al., 2008; Huang et al., 2009; Devi & Maji, 2010). A genipin 
crosslinked gelatin microcapsule with an alginate coating containing B. adolescentis exhibited 
only a 1.21 log CFU mL
-1
 reduction in viable numbers when exposed to SGJ, and released 7.35 
to 7.57 log CFU mL
-1
 of viable probiotics in SIF (Annan et al., 2008). It has been proposed that 
factors contributing to the protective nature of the wall material included: the increased numbers 
and strengths of the covalent bonds created by genipin crosslinking, and/or the increase in wall 
material density created by crosslinking (Berger et al., 2004; Devi & Maji, 2010).  
 
2.6 Capsule coatings 
 The protection of core materials within a microcapsule can also be improved through the 
addition of coating materials such as biopolymers, which provide an additional physical barrier 
to harsh environmental conditions. For example, during transit through the gastrointestinal tract, 
a significant change in pH occurs from ~6 (mouth) to ~2.0 (stomach) back to ~7.0 (intestines) 
which can result in swelling and degradation of the capsule wall (Berger et al., 2004; Devi & 
Maji, 2010). These changes can result in premature release of the core materials, which could 
lead to issues surrounding dose delivery (Iyer et al., 2005). The addition of coatings can be used 
to delay this process by providing an additional physical barrier so as to maintain structural 
integrity of the capsule during transit resulting in a more desirable, delayed release pattern in the 
colon. Capsule coating can be afforded quite simply through the treatment of a protein-based 
microcapsule with an oppositely charged biopolymer such as alginate (negatively charged) or 
chitosan (positively charged) in order to introduce electrostatic binding of the biopolymer coat to 
the surface of the capsule. In some cases (e.g., alginate), treatment with a hardening agent such 
as Ca
2+
 is required (Annan et al., 2008; Hebrard et al., 2010). As with wall materials, a wide 
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variety of biopolymers have been employed as microcapsule coatings including but not limited 
to: chitosan (Iyer et al., 2005), poly L-lysine (Joki et al., 2001) and alginate (Annan et al., 2008). 
The ideal microcapsule coating will affect the thickness, permeability, rheology, environmental 
responsiveness and core release properties of the microcapsule such that it exhibits improved 
stability and release functionality (Buchert et al., 2010).  
 For this research, a napin protein isolate, and chitosan polysaccharide were employed as 
coating materials for the genipin crosslinked legume protein capsules. 
 
2.6.1 Chitosan 
Chitosan is produced from chitin by deacylation to yield a polysaccharide comprised of 
covalently linked β-(14)-2-amino-2-deoxy-D-glucopyranose units. Chitosan is both bio-
compatible and non-toxic, and has found extensive use in the areas of pharmacology, 
biomedicine, agriculture, food, and waste treatment (Dutta et al., 2004; Chang et al., 2008). As a 
coating material, the amino functional groups of chitosan provide an overall positive charge to 
this biopolymer affording the formation of electrostatic interactions with a negatively charged 
wall material (e.g., legume protein) (Peng et al., 2012; Wanasundara, 2011). These electrostatic 
interactions occur without the need of a hardening solution, and result in a microcapsule that may 
exhibit enhanced protection to the core material (e.g., probiotic). Coating with chitosan leads to 
an introduction of bioadhesion properties to the microcapsule, resulting from electrostatic 
interactions at physiological pH (7.3-7.4) between the positively charged groups on chitosan 
(pKa of 6.3) and the negatively charged mucosal surfaces (due to sialic acid; pKa of 2.6) of the 
small intestine (He et al., 1998; Woodley, 2001; Bonferoni et al., 2009). The main advantage of 
microcapsules with bioadhesion properties is an increased residence time in the intestinal system 
for bioactive core material absorption (Hejazi & Amiji 2003; Bowman & Leong, 2006). 
 
2.6.2 Napin  
Napin is a 2S storage protein produced by Brassicaceae family embryos during seed 
development. The Brassicaceae family includes many agriculturally important crops such as 
canola (e.g., Brassica napus). Napin is composed of two polypeptide chains with molecular 
masses of ~4 and ~9 kDa that are covalently linked through disulfide bonds (Ericson et al., 
1986). Napin is rich in both glutamic acid and sulfur-containing amino acids and has a very basic 
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isoelectric point (pI) of ≥ 10 (Wanasundara, 2011). The high overall positive charge of this 
protein under physiological/capsule formation conditions (e.g., pH 7.0), makes it an ideal 
candidate as a coating material when used in conjunction with oppositely charged legume 
proteins. In addition to providing enhanced protection to the core material, napin has been found 
to exhibit minimal digestibility in the presence of human gastric enzymes and is a plant-based 
biopolymer (i.e. when coupled with legume proteins the entire microcapsule would be plant-
based) (Wanasundara, 2011). 
 
2.7 Acid challenge 
The survival of a probiotic can be readily determined by subjecting the organism (free or 
encapsulated) to an acid (HCl) solution with a pH generally ranging from 1 to 3 for 2-3 h, as an 
approximation of stomach conditions (Lee & Heo, 2000; Sultana et al., 2000; Truelstrup-Hansen 
et al., 2002). Because acid exposure is a major detriment to probiotic survival through the 
stomach (Heatley & Sobala, 1993; Marteau et al., 1997), this method can be used with or without 
bile salts, for encapsulated probiotics in place of, or prior to the use of more complicated systems 
(e.g., a Simulation of the Human Intestinal Microbial Ecosystem (SHIME)) as it rapidly provides 
evidence of the protective properties of the wall material (Lee & Heo, 2000; Sultana et al., 2000; 
Truelstrup-Hansen et al., 2002). A limitation of this method is that only one factor (i.e. pH) of 
the body’s gastrointestinal environment is examined. 
Other gastrointestinal environment testing systems have been employed for determining 
the protective ability of encapsulation on probiotics. Simulated gastric juice (SGJ) is a solution 
with a pH of 1.2 to 3.0 that includes bile salts (or NaCl) and pepsin, and is kept at 37˚C to mimic 
the conditions a capsule would experience in the gastrointestinal tract. Simulated intestinal fluid 
(SIF) has a pH of 7.5, is kept at 37˚C and contains a variety of digestive enzymes from exocrine 
cells including amylase, lipase and protease such as trypsin (Hebrard et al., 2010). SGJ and SIF 
are often used in sequence to simulate the gastrointestinal tract (GIT). A SHIME system is a 
more complicated model of the human GIT (De Boever et al., 2000) that can also be used to 
evaluate the functionality of probiotic microcapsules. In this model, five vessels are used in 
sequence to simulate each aspect of the GIT over ~76 h. Each section has a different pH and 
digestive enzyme/bile salt composition (which is maintained throughout) and the final three 
sections are inoculated with bacteria flora commonly found in the GIT, which is also maintained 
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with nutrient addition. Anaerobic conditions and a temperature of 37°C are maintained in each 
vessel and the system is generally stabilized (and bacterial populations characterized) for 3 
weeks prior to use (De Boever et al., 2000). This is generally a very good model, but one 
limitation is that it does not account for the selective absorption of nutrients over time and as 
such is not a perfect representation of the GIT (Hebrard et al., 2010; Sanders & Marco, 2010). 
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3 MATERIALS AND METHODS 
3.1 Materials 
The following materials were generously supplied for this research project. Legume seeds 
were donated by the Crop Development Centre (Saskatoon, SK), and included chickpea (CDC 
Frontier), faba bean (SSNS) and green lentil (CDC Grandora). Fructooligosaccharide powder 
(FOS) (Beneo P95: 95% oligofructose) was supplied by BENEO-Orafti (Tienen, Belgium). 
Napin protein isolate was supplied by Dr. Janitha Wanasundara (Agriculture and Agri-Food 
Canada, Saskatoon, SK). 
The following chemicals and materials were produced by EMD Millipore (Billerica, MA, 
USA) and purchased from VWR International (Mississauga, ON): Lactobacilli De man, Rogosa, 
Sharpe (MRS) media, potassium chloride (KCl), sodium dihydrogen phosphate (NaH2PO4), 
sodium chloride (NaCl), sodium hydroxide (NaOH), sodium phosphate dibasic (Na2HPO4), and 
Tristar N-Point Indicator.  
The following chemicals were purchased from Sigma-Aldrich Canada Ltd. (Oakville, 
ON): 8-anilino-1-naphthalenesulfonic acid (ANS) fluorescent probe, chitosan (low molecular 
weight), L-cysteine hydrochloride monohydrate (L-cys), and polyethylene glycol sorbitan 
monooleate (Tween® 80). 
Glycerol (Acros Organics) and hexane (Certified ACS) were purchased from Fisher 
Scientific (Fair Lawn, NJ, USA). 
Ultra high purity (UHP) N2 and a mixed system containing 80% N2, 10% CO2 and 10% 
H2 were purchased from Praxair Canada Inc. (Saskatoon, SK). 
Bifidobacterium adolescentis ATCC 15703 was purchased from American Type Culture 
Collection (Manassas, VA). 
Genipin powder (98% by HPLC) was purchased from Challenge Bioproducts Co., Ltd 
(Yun-Lin Hsien, Taiwan R.O.C.). 
Commercially defatted soy flour (Cargill: Prolia 200/70) was purchased from Cargill 
Limited (Winnipeg, MB). 
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Bacto-agar buffered peptone water (alkaline peptone water; APW) from BD (Becton, 
Dickinson and Co. Difco Laboratories. Sparks, MD) was obtained through VWR International. 
Hydrochloric acid (HCl) was purchased from VWR International. 
Canola oil was purchased from Loblaw Companies Ltd. (Brampton, ON). 
Petri dishes were purchased from Phoenix Biomedical (Mississauga, ON). 
Potassium dihydrogen orthophosphate (KH2PO4) was purchased from J.T. Baker 
(Phillipsburg, NJ). 
SYTO®-9 nucleic acid stain was purchased from Invitrogen Molecular Probes (Eugene, 
OR). 
Ethanol (95%) was purchased from Commercial Alcohols Inc. (Brampton, ON). 
 All water used in this research, labelled as MQW, was produced from a Millipore Milli-
Q
TM
 water purification system (Millipore Corporation, Milford, MA). 
 
 
3.2 Study 1: The physicochemical properties of legume protein isolates and their ability 
to stabilize oil-water emulsions with and without genipin 
All protein isolates were prepared in MQW and were adjusted to pH 7.0 using 0.1 M 
NaOH and/or 0.1 M HCl (Accumet pH meter, Fisher Scientific, Waltham, MA) followed by 
mechanical stirring at 1000 rpm for 2 h at room temperature (22-23°C) prior to testing, except 
where noted. All experiments were conducted with adjusted (based on the crude protein results 
for each isolate) protein concentrations on a weight basis. All results are reported as the mean ± 
one standard deviation, n = 3. 
 
3.2.1 Legume protein isolate production and proximate analysis 
Legume seeds were initially ground employing a bowl grinder (Cuisinart Mini-Prep 
Plus), followed by a fine grind (IKA A11 basic. IKA Works Inc., Wilmington, NC) to give flour. 
In the case of soy, commercially defatted flour was used as the starting material. Legume flours 
from seed were defatted in triplicate with hexane (1:3; w:v; protein:hexane) for 40 min at room 
temperature (L’Hocine et al., 2006) and then concentrated utilizing a modified isoelectric 
precipitation procedure (Mondor et al., 2009; Boye et al., 2010; Papalamprou et al., 2010). In 
brief, the defatted legume flour was dispersed in MQW at a 1 to 10 (w:v; protein:MQW) ratio, 
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followed by pH adjustment to 9.0 with 1.0 M NaOH so as to facilitate protein solubility. The 
resulting solution was stirred at 1000 rpm (Ikamag Ret-G, IKA Labortechnik, Germany) for 1 h, 
and then centrifuged at 5000 x g for 20 min, at 4˚C (Sorvall RC6+; Thermo Fisher Scientific, 
Waltham, MA). The supernatant was collected for later use, and the process was repeated with a 
1 to 5 (w:v) pellet:MQW ratio. Supernatants from both extractions were pooled and adjusted to 
pH 4.6 with 1.0 M HCl so as to facilitate protein precipitation. The precipitate was collected by 
centrifugation (5000 x g, 20 min, 4˚C); washed with 25 mL of MQW, frozen (-30°C), and then 
freeze dried (Labconco FreeZone, Kansas City, MO) to yield a free flowing powder. Protein 
isolates were stored at 4˚C in sealed tubes for later use. 
The crude ash, lipid, moisture and protein (%N x 6.25 for chickpea, faba bean and lentil; 
x 5.70 for soy) contents for each isolate were determined according to the Association of Official 
Analytical Chemists (AOAC, 2003) methods: 923.03, 920.85, 925.10, and 920.87, respectively. 
The carbohydrate content was determined on the basis of percent differential from 100%. All 
proximate analysis results were performed in triplicate for each protein isolate batch preparation.  
 
3.2.2 Legume protein isolate amino acid composition 
 The amino acid composition of each protein isolate was determined employing AOAC 
Official Methods 985.2 and 988.15 (White et al., 1986; AOAC, 2003; Landry & Delhaye, 1993). 
This work was conducted by POS Bio-Sciences Corp. (Saskatoon, SK). Briefly, to individual 20 
x 150 mm screw cap Pyrex tubes was added 20 mg of legume protein isolate. To each tube was 
added 15.00 mL of 6 N HCl followed by sample flushing with N2. Tubes were then capped and 
placed into an oven at 110°C ± 0.5°C for 20 h. Following acid digestion, the individual amino 
acids were quantified using high pressure liquid chromatography employing the pico-tag amino 
acid analysis system (Waters Corporation, Milford, MA). Sample amino acid concentration was 
normalized for each isolate based on its crude protein content (Section 3.2.1). 
 
3.2.3 Physicochemical properties of legume protein isolates  
3.2.3.1 Protein solubility 
Protein solubility was determined using the following modified (Morr et al., 1985) micro-
Kjeldahl analysis protocol. To a protein content weight of 0.20 g for each protein isolate was 
added 18.00 g of MQW and the resulting suspension was adjusted to pH 7.0 with 0.1 N HCl 
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and/or 0.1 N NaOH. Sample pH was monitored and maintained throughout a 1 h stirring (1000 
rpm) period at room temperature. The total weight of the sample solution was brought to 20.00 g 
with MQW to give a final protein concentration of 1.00% (w/w). The sample solution was then 
allowed to remain static for 10 min before being transferred to a 50 mL tube and centrifuged for 
10 min at 7200 rpm (Morr et al., 1985). A 5.00 g aliquot of the supernatant was taken for micro-
Kjeldahl analysis (Labconco Micro Digester and Labconco Rapid Distillation Apparatus; 
Labconco Co., Kansas City, MO, USA). Protein solubility was determined by dividing the 
nitrogen content of the supernatant by the total nitrogen in the sample (x 100%). 
 
3.2.3.2 Zeta potential 
Overall surface charge of each protein isolate was determined by measuring 
electrophoretic mobility (UE) of prepared protein solutions at pH 7.0 using a Zetasizer Nano-
ZS90 (Malvern Instruments, Westborough, MA). The zeta potential (ζ) was determined from UE 
values employing the Henry equation (Eq. 1):       
   
UE = (2ε ζ f (κα)) / 3η        (1) 
 
where: ε is the permittivity, f(κα) is a function related to the ratio of particle radius (α) and the 
Debye length (κ), and η is the dispersion viscosity. For this work, the Smoluchowski 
approximation, f(κα) of 1.5, was used. Solutions (0.05% w/v) were prepared for each legume 
protein isolate. A 1 mL syringe was used to inject an aliquot of the sample into the zetasizer 
sample cell. A refractive index (RI) of 1.450 was used for each sample; water was used as the 
dispersant (viscosity was 0.8872 cP at 25°C; the RI was 1.330 and the dielectric constant was 
78.5. An equilibrium time of 120 s was used for each analysis followed by 10-100 measurements 
until an acceptable standard deviation was reached, typically 10 measurements were required. 
 
3.2.3.3 Surface hydrophobicity 
Surface hydrophobicity for each legume protein isolate was determined using the 
fluorescent probe, 8-anilino-1-naphthalenesulfonic acid (ANS) (Kato & Nakai, 1980) with 
modifications developed by Wang et al. (2005). Protein solutions (0.10%, w/v) were prepared by 
dispersing the powder in 10 mM sodium phosphate buffer (pH 7.0) for 2 h using a magnetic 
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stirrer (1000 rpm). Each solution was subsequently diluted to obtain protein concentrations of 
0.02%, 0.04%, 0.06%, 0.08% and 0.10% (w/v). To 4 mL of each protein solution (0.02%-0.10%; 
w/v) was added 20 μL of 8 mM ANS solution (in 10 mM sodium phosphate buffer at pH 7.0) 
and the resulting solution was vortexed (Baxter Diagnostics Inc., Deerfield, IL) at setting 10 for 
10 s. Samples were then placed in the dark for 15 min. Fluorescent intensity (FI) was measured 
using a FluoroMax-4 Spectrofluorometer (HoribaJobin Yvon, Kyoto, Japan) with an excitation 
wavelength and slit width of 390 nm and 1 nm, respectively, and an emission wavelength and slit 
width of 470 nm and 1 nm, respectively. FI measurements were also obtained for an ANS blank 
and protein blanks (without ANS) at each concentration. The FI values of these controls were 
both subtracted from the FI values of the ANS-protein samples. The initial slope of the plot of FI 
against % protein concentration was calculated by linear regression analysis and used as an index 
of average sample surface hydrophobicity. 
 
3.2.3.4 Interfacial tension 
The interfacial tensions between prepared legume protein isolate solutions (0.10%; w/w) 
and canola oil was determined according to the Du Noüy ring method using a semi-automatic 
tensiometer (Lauda TD2, GmbH & Co., Lauda-Königshofen, Germany). This value was then 
compared to the interfacial tension between MQW and canola oil (without protein isolates). In 
this procedure, 40 mL of a prepared protein isolate solution was stirred overnight (16-18 h) at 
room temperature. To this solution was added 30 mL of canola oil and the interfacial tension 
between the two discontinuous phases was determined. Interfacial tension was calculated from 
the maximum force (Fmax) exerted on the ring as it was pulled through the interface using the 
following equation (Eq. 2):  
 
γ = Fmax / (4πRβ)        (2) 
 
where, γ is the interfacial tension, R is the radius of the ring (9.55 mm), and β is a correction 
factor that is dependent on the dimensions of the ring and the density difference of the liquids 
used (in these experiments β = 0.1 g/cm3). 
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3.2.4 Crosslinking of legume protein isolates in the presence of genipin 
Individual legume protein isolate solutions at a concentration of 0.10% (w/w) were 
prepared in MQW. After stirring, genipin powder was added to each solution set to achieve final 
concentrations of: 2.5, 5.0, 7.5, and 10.0 mM. The resulting solutions were stirred (1000 rpm) for 
1 h at room temperature and then allowed to crosslink statically for 24 h. An aliquot of each 
solution was removed and sample absorbance at 288 nm was measured using a UV/Vis 
Spectrophotometer (Optizen 2120UV. Mecasys Co. Ltd, Korea.). Blanks consisting of each 
legume protein isolate solution (0.10% w/v) without added genipin were run in conjunction with 
all sample sets. The initial slope of the plot of absorbance at 288 nm versus genipin 
concentration was calculated by linear regression analysis and was used as an index of the 
average genipin induced crosslinking of the legume protein isolates. 
 
3.2.5 Creaming stability of legume protein isolates 
Legume protein isolate solutions were prepared with (10.0 mM) and without genipin to 
determine the impact of crosslinking on creaming stability. Oil in water emulsions (10.0 mL) 
were prepared by homogenizing 5.0 mL of prepared protein solution (0.50% w/w) with 5.0 mL 
of canola oil at 13,000 rpm for 5 min using a homogenizer (Polytron® MR PT 2100, Kinematica 
Inc. Bohemia, NY). Immediately after preparation, emulsions were transferred to a 10 mL sealed 
graduated glass cylinder and subsequent sample separation into an opaque cream layer (top) and 
a turbid aqueous layer (bottom) after 24 h of static treatment at room temperature was 
determined. Percent creaming stability (CS) was calculated using the following equation (Eq. 3): 
 
CS (%) = ((VB – VA) / VB) x 100      (3) 
 
where, VB is the volume of the aqueous protein solution (5.0 mL) before emulsification and VA 
is the volume of the turbid aqueous layer that has ‘fallen out’ of the emulsion after 24 h. 
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3.3 Study 2: Probiotic encapsulation within genipin crosslinked legume protein 
microcapsules 
Legume protein isolate solutions were prepared in MQW, adjusted to pH 7.0 using 0.5 M 
NaOH and/or 0.1 M HCl followed by mechanical stirring at 1000 rpm overnight (~16 h) at room 
temperature prior to encapsulation experiments. All experiments were conducted with adjusted 
(based on the crude protein results for each isolate) protein concentrations on a weight basis. All 
experiments were conducted on separately prepared batches of bacteria/capsules and results are 
reported as the mean ± one standard deviation, n = 3, except where noted. CFU mL-1 
determination was conducted in duplicate for each replicate at each dilution/sampling time; 
where the resultant mean accounts for one experimental replicate. 
 
3.3.1 Growth and enumeration of Bifidobacterium adolescentis 
 Bifidobacterium adolescentis (ATCC 15703) was kept at -70°C in a 1:1 (v:v) suspension 
of glycerol and MRS broth prior to use (Wood, 2010). Viable cell numbers of B. adolescentis 
were obtained by plating of 100 μL aliquots on MRS agar supplemented with 0.05% (w/v) L-cys 
(MRS-cys), after sequential dilutions were made with sterile 10.0% (w/v) alkaline peptone water 
(APW), made from buffered peptone water in MQW. Inoculated plates were incubated at 37°C 
for 48 h under anaerobic conditions (80% N2, 10% CO2 and 10% H2) employing an anaerobic 
chamber (Forma Scientific Inc., Marietta, GA) and colonies were counted manually (Rodrigues 
et al., 2012). 
 
3.3.2 Encapsulation of Bifidobacterium adolescentis 
3.3.2.1 Preparation of Bifidobacterium adolescentis for encapsulation 
Bifidobacterium adolescentis was inoculated into 10.0 mL of MRS-cys broth and 
incubated anaerobically at 37°C for 23 h. The bacterial suspension was centrifuged (Sorvall SS-
1, Ivan Sorvall Inc. Newtown, CT) for 5 min at 1000 x g and the pellet was re-suspended in 1.00 
mL of sterile APW. This protocol was employed to increase initial cell counts. 
 
3.3.2.2 Encapsulation procedure 
Genipin crosslinked, legume protein isolate stabilized water in canola oil emulsions were 
prepared using a technique similar to those reported in literature (Truelstrup-Hansen et al. 2002; 
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Krasaekoopt et al. 2003; Winder et al. 2003). In this procedure, 9.00 mL of protein isolate 
solution (10.00% w/w; with respect to the final volume of 10.00 mL) was prepared for each 
legume protein isolate as previously described. Genipin powder was then added to this mixture 
so as to reach a final concentration of 15.0 mM. To this mixture was added 1.00 mL of the 
concentrated bacterial suspension to bring the final volume to 10.00 mL. The resulting mixture 
was then stirred (1000 rpm) at room temperature for 5 min. This solution (aqueous phase) was 
added to 100.00 g of canola oil and mixed employing an overhead stirrer (Caframo Real Torque 
Digital Stirrer, Wiarton, ON) fixed with a compact straight blade impeller (A231: 1.25") 
(Caframo, Wiarton, ON) for 6 h. Samples were prepared at mixing speeds of 750 and 1000 rpm 
to form a water-in-oil emulsion. Following the 6 h crosslinking and probiotic encapsulation 
period, stirring was terminated and 100.00 g of MQW was added in order to break the emulsion 
into both upper (oil) and lower (aqueous) phases. Due to the amphiphilic nature of the protein 
wall material, capsules remained associated with both phases and emulsion breakdown was 
retarded. Harvesting of capsules from this interface and from the aqueous phase was 
accomplished by centrifugation of ~100 mL of the solution at 1000 x g for 5 min. The upper oil 
phase was removed by pipette and 10.00 mL of 1.00% Tween 80 in MQW was added to the 
aqueous capsule solution. This step was used to maintain capsule dispersion and to limit capsule-
capsule crosslinking/aggregation. An aliquot of the resulting solution was transferred to a 50 mL 
separatory funnel to allow the capsules to settle (~5 min) with any remaining oil migrating to the 
solution surface. Capsules were harvested in solution from the aqueous phase and used 
immediately.  
 
3.3.2.3 Enumeration of encapsulated Bifidobacterium adolescentis  
The level of viable B. adolescentis (CFU mL-1) was determined by vortexing (30 s at the 
highest setting of 8) (Fisher Vortex Genie 2TM. Fisher Scientific. Waltham, MA) a 100 μL aliquot 
of harvested capsule solution in 900 μL of sterile APW, followed by serial dilutions with APW 
and duplicate spread plating of 100 μL aliquots on MRS-cys agar. Inoculated plates were 
incubated under anaerobic conditions at 37°C for 48 h and colonies were manually counted.  
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3.3.3 Effect of stirring speed on the capsule size of genipin induced crosslinked legume 
protein microcapsules  
The effect of stirring speed on capsule size as measured by light scattering was 
investigated at both 750 and 1000 rpm. Capsules were prepared as described in Section 3.3.2.2 
with the exception that 10.00 mL of the aqueous protein isolate solution (10.00% w/w) was 
employed without the addition of probiotic. Capsule size was determined by light scattering 
using a Mastersizer 2000 equipped with a Hydro 2000S wet sample cell (Malvern Instruments, 
Westborough, MA). The measuring parameters of the instrument were set to: 10-20% obscurity; 
850 rpm pump speed; a sample absorbance default of 0.1; and software recommended refractive 
index values of 1.45 and 1.33 for the sample (protein) and dispersant (MQW), respectively. 
Experiments were conducted on duplicate capsule batches, with size analysis for each batch 
performed in triplicate. Data was reported as the volume weighted mean capsule diameter, the 
mode capsule size (of the 100 size bins) and the percentage of capsules with an average size 
>100 μm. 
 
3.3.4 Acid challenge experiments for free and encapsulated Bifidobacterium adolescentis 
 The survival of free and encapsulated B. adolescentis within the four protein isolate wall 
materials were tested employing a simple acid challenge experiment over a 2 h duration at room 
temperature. A 10.00 g aliquot of capsule solution (Section 3.3.2.2) was added to 90.00 mL of 
pH 2.0 MQW (pH adjusted and maintained at this value employing 2.0 M HCl/0.5 M NaOH) 
with gentle stirring at room temperature. Sample aliquots of 100 μL were removed at times 0, 5, 
10, 20, 30, 60, 90 and 120 min, and were immediately diluted (1:10) in sterile APW to partially 
neutralize the solution without over-dilution. Diluted sample aliquots were vigorously vortexed 
(highest setting: 8) for 30 s so as to break any intact capsules followed by serial dilution for 
enumeration studies that were based on acid treatment time. As examples, the CPI-capsules at 
time 0 and 60 min were serially diluted to 10-5 and 10-3, respectively. Serially diluted samples 
were plated and enumerated as outlined in Section 3.3.2.3.  
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3.3.5 Effects of biopolymer coatings and/or prebiotics on CPI encapsulated 
Bifidobacterium adolescentis survival in acid challenge experiments 
CPI was selected as the encapsulation matrix based on the higher CFU mL-1 numbers 
observed post encapsulation (Section 4.3.2) for this material relative to FPI and LPI. Chitosan 
(low molecular weight) and napin biopolymers were used as coating materials. Capsule coatings 
were prepared by the addition of a 10.00 mL aliquot of capsules (Section 3.3.2.2) to 10.00 mL of 
biopolymer solution (0.50%, w/w in phosphate buffered saline, pH 7.0) followed by gentle 
stirring (~120 rpm) for 30 min. The resulting mixture was directly added to the acid challenge 
solution and the same experimental protocol as outlined in Section 3.3.4 was followed with the 
exception that 100.00 mL of pH 2.0 solution was used. The increased volume (e.g., capsule and 
coating solutions = 20.00 mL) added to the pH 2.0 solution (total volume = 120.00 mL) was 
accounted for when determining the final number of survivors (CFU mL-1), as this initial dilution 
was not 1 in 10, through multiplication by a factor of 1.2. 
 For the prebiotic experiments, 1.00% (w/w) fructooligosaccharide powder (FOS) was 
added to the original protein/genipin solution prior to the addition of the concentrated bacterial 
suspension, as described in Section 3.3.2.2. The acid challenge protocol outlined in Section 3.3.4 
was followed for the following experiments, each encapsulating B. adolescentis: CPI + FOS, CPI 
+ FOS + chitosan coating, and CPI + FOS + napin coating. 
 
 3.3.6 Imaging of chickpea protein microcapsules  
A Zeiss Axiostar Plus (240 V) light microscope (Carl Zeiss Canada Ltd. Toronto, ON) 
was used to examine the size and surface morphology of CPI capsules, containing B. 
adolescentis, with and without a napin coating. Light microscopy digital images, of unmodified 
harvested capsule solution (Section 3.3.2.2), were made using an AxioCam MRc camera (Carl 
Zeiss Canada Ltd. Toronto, ON) mounted on a microscope with either 10x or 40x objectives. The 
software used for light microscopy digital imaging (including scale bar addition) was AxioVision 
software version 3.1.2.1 (2002).  
The resultant digital images were analyzed using ImageJ (Image processing and analysis 
in JAVA) software version 1.45s (Wayne Rasband. National Institutes of Health, USA) as an 
alternate size analysis method. To do so, the captured digital light microscopy images (JPEG file 
format) were adjusted for color threshold (Figure 3.1) to allow the program to distinguish CPI 
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capsules from the background capsule solution matrix. Limits to particle area (3 – 1000 μm2) 
were set in order to exclude air bubbles, free bacteria, protein ‘clumps’, background noise, etc. 
from the size analysis. The ImageJ software was then used to run an automated size analysis of 
the resultant images (e.g., Figure 3.1b) to calculate the area of each particle, which then could be 
converted to particle diameter (Eq. 4) assuming circular particle shape. The average particle size 
of the capsules with and without a napin coating was determined over multiple (n = 5) fields of 
view. 
      (4) 
 
A Zeiss Standard 20 (115 V) microscope equipped with a UV lamp (5 Amp; Slo-Blo) 
(Carl Zeiss Canada Ltd. Toronto, ON) was used to examine the presence and distribution of B. 
adolescentis cells throughout uncoated CPI capsules. In order to visualize cells by fluorescence 
the SYTO®-9 nucleic acid stain was utilized. SYTO®-9 is a membrane penetrative, green 
fluorescent nucleic acid dye which is capable of staining live cells (Bunthof et al., 2001; Zotta et 
al., 2012). To 1.00 mL of harvested capsule solution was added 3.0 μL of SYTO®-9 and the 
mixture was then kept in the dark for 30 min prior to examination. All fluorescent microscopy 
digital images of the stained capsule solution were taken with a microscope mounted 
Photometrics SenSys® camera (Roper Scientific Inc. Tucson, AZ) using either 10x, 16x or 100x 
objective lenses. The software used for fluorescent microscopy imaging was RS Image software 
version 1.7.3 (2001) (Roper Scientific Inc. Tucson, AZ). The scale of the fluorescent microscopy 
digital images was determined using a 0.01-0.1mm stage micrometer (Bausch & Lomb Canada 
Inc. Vaughan, ON,). 
 
3.4 Statistics 
All sample data is reported as the mean ± one standard deviation. A one way analysis of 
variance (ANOVA) with Holm-Sidak post-hoc test for pairwise comparison procedures was used 
to detect significant differences (p<0.05) between protein levels within the isolate products and 
between capsule sizes produced based on stir speed. An ANOVA with a Scheffe post-hoc test 
and T-testing were used to determine statistical differences (p<0.05) in physicochemical, 
crosslinking and encapsulating properties as a function of legume source. Pearson comparison 

circleofArea
Diameter  2
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and a general linear model with backwise stepwise regression were used to determine the ability 
of legume protein isolate physicochemical properties, without crosslinking, to predict creaming 
stability in legume protein isolate stabilized emulsions. All statistical analyses were performed 
using SigmaPlot 12.0 software (Systat Software, Inc. Chicago, IL). 
 
 
Figure 3.1  Light microscopy digital images of CPI capsules at 400x magnification before (A) 
and after (B) colour threshold adjustment for ImageJ particle size analysis.
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4 RESULTS AND DISCUSSION 
 
4.1 Study 1: The physicochemical properties of legume protein isolates and their ability 
to stabilize oil-water emulsions with and without genipin 
 
4.1.1 Composition of legume protein isolates  
Protein isolates were prepared from raw chickpeas, faba beans and lentils as well as 
defatted soy flour using isoelectric precipitation. Proximate compositions of the resulting isolates 
are shown in Table 4.1. Protein content (on a wet weight basis; (w.b.)) was determined to be 
~85.8%, ~86.3%, ~83.8% and ~90.9% for CPI, FPI, LPI and SPI, respectively. Differences in 
protein content among isolates, however, were not significant (p>0.05). As there is no universal 
scheme for classifying legume protein products, all materials were deemed to be an isolate rather 
than a concentrate in the present study. In the case of soy, Pearson (1983) developed criteria 
requiring a minimum protein content of 85% on a dry weight basis (using a nitrogen conversion 
factor of 6.25) to be classified as an isolate. When protein levels were converted from a wet to 
dry basis in the present study, utilizing the 6.25 conversion factor (5.70 for SPI), the legume 
protein levels were ~87.6%, ~89.8%, ~91.6%, and ~97.1% (dry weight basis) for CPI, FPI, LPI 
and SPI, respectively. The isoelectric precipitation method for protein extraction typically 
involves hydrating defatted flour at alkali pH (9.0) to solubilize the proteins, followed by 
centrifugation to remove insoluble matter (e.g., fibre, carbohydrates), followed by pH adjustment 
to near the legume protein’s isoelectric point (pI) to induce precipitation. At their pI (~4.5-5.0), 
legume proteins assume a net neutral charge and tend to aggregate and fall out of solution. 
Isoelectric precipitation typically yields mainly globulin proteins (Papalamprou et al., 2010), 
whereas other extraction methods, such as salt extraction, yield isolates comprised of a mixture 
of globulins and albumins (Liu et al., 2008). Protein levels in the present study were comparable 
to others found in literature. For example, Can Karaca et al. (2011) using similar legumes and a 
similar extraction method reported protein levels of ~85.4%, ~84.1%, ~81.9%, and ~87.6% for 
CPI, FPI, LPI and SPI respectively. In addition, protein levels on a dry weight basis of ~90.2% 
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and ~78.0% have been reported for LPI (Joshi et al., 2012) and CPI (Sánchez-Vioque et al., 
1999) respectively, when prepared using similar isoelectric precipitation extraction procedures. 
 
Table 4.1  Proximate composition of chickpea (CPI), faba bean (FPI), lentil (LPI) and soy (SPI) 
protein isolates. Data represents the mean ± one standard deviation (n=3). 
 
Sample Protein 
(%, w.b.) 
Moisture 
(%) 
Lipid 
(%, w.b.) 
Ash 
(%, w.b.) 
Carbohydrate 
(%, w.b.)  
CPI 85.76 ± 0.26 2.39 ± 0.00 0.83 ± 0.04 4.41 ± 3.64 6.89 
FPI 86.30 ± 1.26 3.85 ± 0.05 <LOD
*
 3.89 ± 1.35 5.96 
LPI 83.81 ± 1.32 8.48 ± 0.05 0.77 ± 0.01 3.83 ± 1.27 3.11 
SPI 90.86 ± 5.20 6.41 ± 0.01 <LOD
*
 2.19 ± 0.07 0.54 
*
Below limit of detection (<LOD). 
 
Proximate analysis revealed very low lipid levels (≤ 0.83%) within the isolates due to the 
defatting procedure. These low lipid levels were not expected to hinder the dispersion of isolates 
in solution (MQW) during physicochemical testing. Removal of lipids prior to the extraction 
process helps reduce protein-lipid interactions from occurring, which would inhibit protein 
solubility and therefore limit isolation (Leyva-Lopez et al., 1995). Moisture levels for isolates 
were found to be ~2.4%, ~3.9%, ~6.4% and ~8.5% for CPI, FPI, SPI and LPI, respectively, 
reflecting either the efficiency of the freeze drying process or the relative strength of protein-
water interactions (Table 4.1). Ash contents of ~2.2%, ~3.8%, ~3.9% and ~4.4% (w.b.) for SPI, 
LPI, FPI and CPI respectively and carbohydrate levels of ~0.5%, ~3.1%, ~6.0%, and ~6.9% 
(w.b.), by differentiation from 100%, for SPI, LPI, FPI and CPI respectively were determined for 
these materials (Table 4.1). These proximate composition values were similar to those reported 
in literature for legume protein isolates produced by similar isoelectric precipitation procedures. 
As examples, Sánchez-Vioque et al.(1999) reported that a CPI produced by isoelectric 
precipitation had a proximate composition of ~78.0%, ~3.3%, 3.5%, ~2.9% and ~11.8% for 
protein, moisture, lipid, ash and carbohydrate (by difference) respectively on a dry weight basis. 
In addition Okezie & Bello (1988) reported protein (%N x 6.25), moisture, crude fat, ash and 
carbohydrate levels of ~90%, ~4.0%, ~0.0%, ~6.0% and ~4.2% respectively for a winged bean 
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protein isolate produced by isoelectric precipitation and ~97.0%, ~4.7%, ~0.0%, ~3.4% and 
~0.0% respectively for a industrially produced SPI. 
Amino acid profiles for each protein isolate (normalized to 100% based on the protein 
content of each sample) are given in Table 4.2. Lysine content is of particular importance 
because of its reactivity with genipin, the crosslinking agent used in this study (Butler et al., 
2003; Nickerson et al., 2006a; Maji & Hussain, 2008). Lysine contents for the CPI, FPI, LPI and 
SPI products were found to be ~6.3%, ~6.0%, ~6.8% and ~5.7% respectively. Similar lysine 
contents should correspond to similar crosslinking potential with genipin, however, within a 
MQW in oil emulsion setting, lysine residue exposure to genipin (within the aqueous phase) may 
be altered as proteins unfold and re-orientate at the oil-water interface (McClements, 2004; 
Damodaran, 2005). Lysine levels are comparable to those reported for protein isolates in 
literature. For example, Vioque et al. (2012) reported a ~7.0% lysine level for a FPI prepared by 
isoelectric precipitation and Okezie & Bello (1988) reported that an industrially produced SPI 
had a lysine content of 6.1%. In addition, Iqbal et al. (2006) reported lysine contents (adjusted on 
the basis of protein content) for four legumes with values of: ~7.2% (chickpea), ~7.5% (cowpea), 
~7.0% (lentil) and ~8.1% (green pea). 
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Table 4.2 Normalized amino acid profiles (%) of chickpea (CPI), faba bean (FPI), lentil 
(LPI) and soy (SPI) protein isolates. 
Amino acid CPI FPI LPI SPI 
Phenylalanine 6.40 4.42 5.70 5.02 
Isoleucine 4.28 4.38 4.82 4.20 
Tryptophan 0.83 0.91 0.83 1.29 
Leucine 7.76 7.82 8.19 7.11 
Valine 4.22 4.64 4.96 3.93 
Methionine 1.50 0.80 0.95 1.31 
Tyrosine 2.99 3.88 3.79 3.54 
Cysteine 1.17 0.96 0.77 1.31 
Alanine 3.85 3.99 4.03 3.23 
Threonine 3.34 3.81 3.77 3.57 
Histidine 3.04 3.09 2.90 2.95 
Glycine 3.63 4.12 3.84 3.76 
Serine 6.88 6.77 6.97 6.46 
Arginine 9.51 9.72 8.76 7.81 
Lysine 6.31 5.95 6.75 5.68 
(Glutamic  acid + Glutamine) 16.68 17.59 16.45 20.82 
Proline 4.27 4.52 4.24 4.98 
(Aspartic acid + Aspargine) 13.34 12.63 12.28 13.02 
 100 100 100 100 
 
 
4.1.2 Physicochemical properties of legume protein isolates 
4.1.2.1 Surface characteristics 
 The surface charge or zeta potential values for CPI, FPI, LPI and SPI products at pH 7.0 
are shown in Figure 4.1. An analysis of variance showed that all isolates were statistically similar 
(p>0.05), at -47.7, -46.4, -47.2 and -44.3 mV for CPI, FPI, LPI and SPI, respectively. Protein 
isolates in this study carried a net negative charge at pH 7.0, as all were above their isoelectric 
points (where zeta potential is 0 mV). The net negative charge at pH 7.0 arises primarily from 
41 
 
the negatively charged R groups found on the aspartate (pKa = 3.65) and glutamate (pKa = 4.25) 
amino acids spatially located on the protein surface (Nelson & Cox, 2005). Can Karaca et al. 
(2011) and Tang & Sun (2011) reported the isoelectric point of legume globulin proteins to be 
~4.5. Surface charge values from this study were similar to those reported in literature. For 
example, Joshi et al. (2012) reported the surface charge of LPI at pH 7.0 to be -43.3 mV 
compared to values of ~-55 mV for WPI and BSA. In addition, Tang & Sun (2011) reported zeta 
potential values at pH 7.0 of ~-40 mV for legume vicilin proteins isolated from kidney, red and 
mung beans. Having a high protein surface charge is important during the formation of 
emulsions, as it enhances protein solubility due to electrostatic repulsion between negatively 
charged proteins, promotes greater hydration of proteins in solution or protein-water interactions 
resulting in protein migration to the oil-water interface (Schwenke, 2001; McClements, 2004; 
Damodaran, 2005). High surface charges also play a role in maintaining emulsion stability, as 
they induce an electric charge (dependant on pH) to the viscoelastic film surrounding the 
discontinuous droplets. A charged emulsion droplet surface repels others, with a similar charge, 
to inhibit coalescence and flocculation, which are mechanisms for emulsion instability 
(McClements, 2004; Damodaran, 2005).  
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Figure 4.1  Zeta potential (mV) of chickpea (CPI), faba bean (FPI), lentil (LPI) and soy (SPI) 
protein isolates at pH 7.0. Data represent the mean ± one standard deviation 
(n=3). Data with same letters signifies no statistical differences (p>0.05).  
 
Fluorescence spectroscopy can be a sensitive tool for protein analysis such as, structural 
changes, folding, aggregation, surface hydrophobicity; based on the intrinsically fluorescent 
amino acid tryptophan and tyrosine to some degree, and through the use of fluorescent dyes such 
as ANS. The interaction of dye with protein leads to changes in fluorescence, after excitation, 
which is the basis of protein characterisation by this method (Hawe et al., 2008). ANS has very 
low fluorescence in aqueous solution, but becomes highly fluorescent when adsorbed onto 
hydrophobic binding sites spatially distributed on the protein surface. Ion pairing between the 
negatively charged sulfonate groups of ANS and positively charged amino acids (histidine, 
lysine and arginine) also plays a role in dye adsorption to the protein surface. Energy absorption 
by the dye molecule leads to several spectroscopic events including but not limited to: 
vibrational, solvent and fluorescence relaxations to ground state. In the case of fluorescence, 
emission occurs when electrons fall from the lowest vibrational state to ground state (Hawe et 
al., 2008). Fluorescence magnitude is influenced by solvent polarity, viscosity and temperature, 
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or processing factors that impact protein conformation and exposure of buried hydrophobic 
groups.  
The average surface hydrophobicity was determined by the ANS fluorescent probe 
binding method for CPI, FPI, LPI and SPI products at pH 7.0 and is given in Figure 4.2. An 
analysis of variance indicated that CPI was significantly higher (~137.5 arbitrary units, A.U.) 
(p<0.05) than the other isolates, followed by SPI (~72.8 A.U.) and FPI (~70.4 A.U.) which were 
similar in magnitude (p<0.05), and then FPI (~24.4 A.U.) (p<0.05). Tang & Sun (2011) reported 
a surface hydrophobicity range of ~149 - ~259 A.U. for vicilin isolates produced from kidney, 
red and mung beans. Can Karaca et al. (2011) reported a similar hydrophobicity pattern for these 
particular legume protein isolates of, CPI > LPI > SPI = FPI with surface hydrophobicity values 
(~55 – 80 A.U.), which were generally lower than those reported in this study. The surface 
hydrophobicity values determined in this study were different than those reported in the 
aforementioned literature citations, which may be due to the use of different protein 
concentrations in slope generation. 
A protein with high surface hydrophobicity can readily align at the oil-water interface, 
and re-orientate itself such that its hydrophobic moieties position themselves towards the oil 
phase and the hydrophilic moieties towards the aqueous phase (Schwenke, 2001; Damodaran, 
2005). Depending on its amino acid sequence and the level of folding/unfolding of a protein at 
the interface, various loops or tails can develop in which sections of the protein extend from the 
surface of the droplet into the continuous phase creating a steric hindrance that reduces the 
likelihood of aggregation, flocculation and coalescence between neighbouring droplets. 
(Schwenke, 2001; McClements, 2004; Damodaran, 2005). The surface characteristics of a 
protein within an emulsion are reliant on the extent of its interactions with the dispersive 
solvent/phase, and with the interface. Accessible surface area, coupled with unfolding and re-
orientation at the interface, may explain how protein isolates with different physicochemical 
properties may exhibit similar emulsification properties and vice versa (Schwenke, 2001). 
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Figure 4.2  Average surface hydrophobicity (arbitrary units, A.U.) of chickpea (CPI), faba 
bean (FPI), lentil (LPI) and soy (SPI) protein isolates at pH 7.0. Data represent the 
mean ± one standard deviation (n=3). Data with different letters signifies a 
statistical difference (p>0.05).  
 
 
4.1.2.2 Protein solubility 
 Percent protein solubility at pH 7.0 was determined for all legume protein isolates (Figure 
4.3). An analysis of variance revealed that all isolates displayed significantly different (p<0.05) 
solubility values, which were found to be the highest for CPI (~94%), followed by LPI (~90%), 
FPI (~85%) and SPI (~50%). Similar solubility for legume protein isolates prepared by 
isoelectric precipitation has been reported in literature by Sánchez-Vioque et al. (1999), and 
Carbonaro et al. (1997) for CPI (>80%), and for FPI, LPI and CPI (all >80%). Solubility is 
mediated by the balance of protein-protein and protein-solvent (aqueous phase) interactions; the 
latter promoting solubility, which can further be influenced by environmental factors such as 
temperature, pH and ionic strength (McClements, 2007; Can Karaca et al., 2011), and by 
processing (e.g., extraction or post-extraction treatments) (Kinsella, 1979). High surface charge 
is important for fostering sufficient electrostatic repulsion between proteins, such that they can 
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overcome electrostatic and van der Waals attractive forces, so as to remain dispersed in solution. 
In the present study, SPI displayed the lowest surface charge (~-44 mV) relative to the other 
three isolates (Figure 4.1), which may have contributed to its reduced solubility. However, 
solubility of proteins is influenced by other factors, such as salts, conformation, pH, level of 
association/disassociation and hydrophobicity (Carbonaro et al., 1997; McClements, 2004; 
Damodaran, 2005). In general, proteins that have high surface hydrophobicity tend to be 
negatively correlated with solubility (Can Karaca et al., 2011), however in the present study, CPI 
showed both the highest solubility and surface hydrophobicity which reflects the complexity 
behind fully understanding the structure-function-mechanism related to protein solubility. This 
could be a factor not of the average surface characteristics (e.g., charge vs hydrophobicity), but 
rather of the apparent surface characteristics, which are influenced by the frequency and 
distribution of charges on the folded protein surface (Schwenke, 2001; Tang & Sun, 2011).  
 
Figure 4.3 Average protein solubility (%) of chickpea (CPI), faba bean (FPI), lentil (LPI) and 
soy (SPI) protein isolates at pH 7.0. Data represent the mean ± one standard 
deviation (n=3). Data with different letters signifies a statistical difference 
(p>0.05).  
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4.1.2.3 Interfacial properties 
During emulsion formation, proteins migrate to the oil-water interface and re-align to 
allow positioning of hydrophobic groups towards the oil phase and hydrophilic groups towards 
the aqueous phase. This is followed by the formation of a viscoelastic film that resists 
flocculation or coalescence through electrostatic repulsive forces (depending on the pH) and 
steric stabilization (Schwenke, 2001; McClements, 2004; Damodaran, 2005; Joshi et al., 2012). 
The ability of a protein to align at the interface can be described by its ability to reduce the 
interfacial tension between oil and water phases. Interfacial tension is a measurement of the force 
(e.g., energy) required to move a probe (e.g., du Nöuy ring) through an interface (Can Karaca et 
al., 2011). Its ability to reduce this tension will enable smaller emulsion droplets to form, to give 
a more stable emulsion (Damodaran, 2005). In the present study, interfacial tension was 
measured through a MQW-canola oil interface for CPI, FPI, LPI and SPI products at pH 7.0, and 
is shown in Figure 4.4. Each of the four legume protein isolates, when added to the aqueous 
phase, were shown to reduce the interfacial tension of a MQW-canola oil interface from 16.73 
mN/m  to values ranging from 8.23-8.62 mN/m (Figure 4.4), however no difference in interfacial 
reduction was found regardless of protein type (p>0.05). Values were similar to those reported in 
the literature for a protein induced reduction of interfacial tension between water and oil, 
although materials and/or methods differed. For example, Joshi et al. (2012) reported that the 
interfacial tension as measured by the pendant drop method for an olive oil-water mixture with 
LPI added at 10 mg/mL to be ~12 mN/m; reduced from ~22 mN/m without protein. This was 
reported to be typical for other non-legume globular proteins at an oil-water interface and the 
reduction of ~10 mN/m is comparable to the ~8.3 mN/m reduction caused by the addition of 
legume protein isolates in this study. Can Karaca et al. (2011) also reported a similar magnitude 
in the reduction of interfacial tension (~6.1 mN/m) at a flaxseed oil-water interface with the 
inclusion of CPI, FPI, LPI and SPI (0.25% w/w), when compared to water-oil alone. 
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Figure 4.4 Average interfacial tension (mN/m) of chickpea (CPI), faba bean (FPI), lentil 
(LPI) and soy (SPI) protein isolates at pH 7.0 for a MQW-canola oil interface. 
Data represent the mean ± one standard deviation (n=3). Data with similar letters 
signifies no statistical differences (p>0.05).  
 
4.1.3 Reactivity of genipin to the legume protein isolates 
Genipin is considered to be a novel, non-toxic covalent crosslinking agent produced by 
Gardenia fruit (Sung et al., 1999; Mi et al., 2000; Butler et al., 2003; Nickerson et al., 2006b). 
Researchers have used genipin to crosslink a variety of materials including, but not limited to: 
bovine serum albumin (BSA), chitosan, gelatin, gelatin-carrageenan mixtures as well as soy and 
whey proteins. These materials have been used for a variety of purposes including: wound 
dressings, hydrogels, micro/nanoparticles and films (Butler et al., 2003; Annan et al., 2008; 
Huang et al., 2009; Devi & Maji, 2010). To our knowledge, there has been little work on its 
reactivity with legume proteins and potential for use in stabilizing emulsions. To investigate the 
crosslinking ability of genipin to our legume protein isolates, sample absorbance was monitored 
at 288 nm as a function of genipin concentration. A linear increase (R
2
 range of 0.870-0.967) 
was found as genipin concentrations increased from 2.5 to 10 mM when in the presence of the 
legume protein isolates (Figure 4.5). As such, the slopes were taken as an index of legume 
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protein isolate-genipin crosslinking reactivity. Slopes for CPI, FPI, LPI and SPI-genipin 
reactions were found to be similar at 0.0369, 0.0377, 0.0305 and 0.0378, respectively. The 
differences observed in the spectroscopic results for the four legume protein isolates may be 
explained by differences in the spatial arrangement and surface exposure of lysine groups, as 
well as protein flexibility. Spectrophotometric results have been used previously to measure 
polymer crosslinking with genipin. For example, Butler et al. (2003) found that an absorbance 
peak developed at 605 nm in a glucosamine:genipin mixture, which increased in intensity as a 
function of reaction time. The authors also reported the development of peaks at 240 and 280 nm 
in chitosan:genipin mixtures, which they related to polymer crosslinking.  
 
Figure 4.5 Absorbance at 288 nm of mixtures of chickpea (CPI), faba bean (FPI), lentil (LPI) 
and soy (SPI) protein isolates, as well as a genipin (GP)-MQW blank, as a 
function of genipin concentration at pH 7.0 after crosslinking for 24 h. Data 
represent the mean ± one standard deviation (n=3).  
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The proposed mechanism for protein-genipin crosslinking involves the following two 
reactions: (1) a nucleophilic substitution to the dihydropyran ring of genipin followed by a 
Schiff’s base reaction; and (2) a separate Schiff’s base reaction with the ester group of the 
genipin molecule. For both reactions, a primary amine group from the protein is required for 
crosslinking with genipin (Butler et al. 2003). The first reaction is initiated by nucleophilic attack 
at C3 of genipin by a primary amine group on the protein that results in dihydropyran ring 
opening and formation of an aldehyde group and secondary amine. The ring then closes as the 
secondary amine reacts with the aldehyde group, to form a heterocyclic ring bound to a protein 
molecule (Butler et al., 2003). The second reaction is a SN2 nucleophilic attack at the ester group 
on the genipin molecule by a primary amine on the protein so as to produce an amide linkage. 
The evidence for these two reaction mechanisms was based on 
13
C nuclear magnetic resonance 
(NMR), infrared spectroscopy (IR) and rheological data collected during genipin crosslinking 
experiments with chitosan, BSA, gelatin and glucosamine (Butler et al. 2003).  
 
4.1.4 Creaming stability of legume protein isolates with and without genipin 
The creaming stability of MQW–canola oil emulsions, stabilized with CPI, LPI, FPI and 
SPI were investigated over a 24 h period with and without genipin at pH 7.0, and are shown in 
Figure 4.6. An analysis of variance revealed that overall, protein stabilized emulsions prepared 
with genipin showed increased stability (57.75%) relative to those without (51.08%), regardless 
of protein type (p<0.05). Emulsion stability (without genipin) was found to be significantly 
different (p<0.001), where SPI showed the greatest stability (~57.7%), followed by LPI 
(~52.3%), FPI (~49.3%) and then CPI (~45.0%) (Figure 4.6). A similar trend was found for 
protein type in the presence of genipin. When relating the physicochemical results to creaming 
stability (without genipin) using the Pearson correlation, it was found that only solubility was 
(negatively) correlated (r = -0.795, p<0.01). A backward stepwise regression model, which was 
able to explain 63.2% of data variability (Eq. 5), found a similar conclusion where only solubility 
was a significant factor (F = 17.142, p<0.01): 
  
CS = [-0.229 x solubility] + 69.326.      (5)  
Overall, only protein solubility was found to be significantly (p<0.01) correlated with creaming 
stability.  
50 
 
Creaming stability refers to the ability of a protein stabilized emulsion to resist creaming, 
where oil droplets flocculate and coalescence, then migrate upwards due to the density difference 
from MQW (Damodaran, 2005; Liu et al., 2010; Can Karaca et al., 2011). The ability of an 
emulsion to resist creaming is largely dependent on droplet size and density contrast between 
phases (McClements, 2007). In the present study, it was hypothesized that legume proteins acted 
to stabilize the emulsions by first migrating to, and then re-aligning at the canola oil-MQW 
interface to form a viscoelastic film during emulsion formation. This film maintains droplet size 
by resisting flocculation and coalescence through electrostatic repulsive forces (negative zeta 
potential) and steric hindrance, and in the presence of genipin, was presumed to become stronger 
and more resistant to punctures, etc. (Damodaran, 2005; McClements, 2007).  
 
 
Figure 4.6 Average creaming stability (%) of chickpea (CPI), faba bean (FPI), lentil (LPI) 
and soy (SPI) protein-stabilized canola oil-MQW emulsions at pH 7.0, with and 
without 10 mM genipin (GP) after 24 h. Data represent the mean ± one standard 
deviation (n=3). Data with different letters signifies a statistical difference 
(p>0.05) for legume proteins without GP.  
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4.1.5 Link to study 2 
 From Study 1 a great deal of knowledge on the physicochemical properties of the four 
legume protein isolates was obtained. Of significant importance were their emulsification and 
genipin crosslinking potentials. These properties were exploited so as to examine their potential 
as microencapsulating agents for the probiotic B. adolescentis in a water-in-oil emulsion system 
employing genipin as the crosslinking agent. During encapsulation, emulsions are stirred for 6 h 
to allow sufficient time for the genipin reaction to occur; forming both intra- and inter- molecular 
covalent crosslinks on proteins surrounding droplets to form a capsule. Study 1 was important, 
while working with an oil-in-water emulsion, as knowledge gained concerning the 
physicochemical properties of the legume proteins and their affinity of genipin in the presence of 
oils will provide a greater understanding of the systems as a whole. The goal of this study was to 
design an emulsification procedure to produce capsules of <100 µm  in diameter that would 
show increased probiotic protection in an acid challenge system. 
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4.2 Study 2: Probiotic encapsulation within genipin crosslinked legume protein isolate 
microcapsules 
4.2.1 Growth and enumeration of Bifidobacterium adolescentis 
Bifidobacterium adolescentis was found to reach 9.26 ± 0.42 log CFU mL
-1
 (n=12) in 
MRS-cys broth after ~22-24 h of anaerobic growth at 37°C. Similar maximum viable cell counts 
were reported by Wood (2010) using this same organism under the same growth conditions. 
These viable cell levels were reported to correspond with the stationary phase of the bacterial 
growth cycle (Wood, 2010). At this growth stage bacteria may enter a stress resistant state, 
including acid tolerance, so as to make them more robust, which may be advantageous for their 
survival through the encapsulation process (Hengge-Aronis, 1993; Hartke et al., 1994; Wood, 
2010). B. adolescentis was selected for this project because it is generally regarded as an acid 
sensitive probiotic (Fuller, 1992; Lee & Heo, 2000; Picot & Lacroix, 2004) and builds off earlier 
research by our group (Wood, 2010; Klemmer et al., 2011). In the present study, it was proposed 
that encapsulation of B. adolescentis within the stationary phase of growth will enhance their 
survival during the encapsulation process and acid tolerance tests. Based on literature, it is 
generally accepted that at least 7.0 log CFU mL
-1
 of a probiotic is required to reach the colon in a 
viable state in order for any benefit to be recognized by the host (Bouhnik, 1993; Krasaekoopt et 
al., 2003). 
 
4.2.2 Encapsulation of Bifidobacterium adolescentis 
Conventional practices for encapsulating probiotics within micron-sized capsules involve 
the use of emulsion-based technology and polysaccharide-based materials, including: alginate 
(Truelstrup-Hansen et al., 2002), cellulose acetate phthalate (CAP) (Favaro-Trindale & Grosso, 
2002), or biopolymer mixtures, such as alginate-starch (Sultana et al., 2000) or κ-carrageenan-
locust bean gum (Audet et al., 1988). Polysaccharides are highly advantageous as wall materials 
due to their low cost and ease of crosslinking with ions (e.g., alginate/pectin with calcium) 
however, at sizes that are negligible to sensory perception (<100 µm) such capsules regularly fail 
at protecting probiotics during acid challenge tests. A typical encapsulation process involves 
dispersing a mixture of polysaccharides and probiotics within a continuous phase of vegetable oil 
to create a water-in-oil emulsion. Depending on the level and duration of shear, the droplet size 
within the emulsion can be controlled. After a set stir time, a small amount of calcium ion 
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solution is added to induce gelation of the polysaccharide rich droplets, followed by a larger 
volume of the ionic solution to break the emulsion and induce droplet hardening. Following 
breakage of the emulsion, capsules (i.e. hardened droplets) fall to the bottom of the aqueous 
phase due to their low affinity with the water-oil interface, and can be harvested. 
Literature describes variable success for polysaccharide-based encapsulation of probiotics 
when challenged by acidic conditions similar to those found in the human GIT. For example, 
Truelstrup-Hansen et al. (2002) encapsulated B. adolescentis within alginate-based capsules of 
~20 and ~70 µm in diameter at levels of 6.0-8.0 log CFU mL-1. However, the authors reported a 
~5.0 log reduction in CFU mL-1 when exposed to a SGJ at pH 2.0 within 30 min. O’Riordan et 
al. (2001) encapsulated Bifidobacterium PL1 within waxy maize starch based capsules ~5 μm in 
diameter at levels of ~6.6 log CFU mL-1. However, after exposure to an acid challenge at pH 2.8 
for both 3 and 6 h, encapsulated probiotic levels were reduced below detectable limits, and the 
authors reported that this capsule formulation offered no additional protection over free cells. In 
contrast, Favaro-Trindale & Grosso (2002) encapsulated B. lactis and L. acidophilus using CAP 
as a wall material at levels of ~7 log CFU mL-1 in capsules with an average size of 22 μm. 
Probiotic reduction of ~1 log CFU mL-1 was reported for both organisms after an acid challenge 
at pH 1 for 2 h, indicating that this formulation increased core material acid resistance. 
Modifying the encapsulation process to better suit protein wall materials faces a number 
of challenges. First, a higher polymer concentration is generally needed to form a capsule when 
compared to that of a polysaccharide due to differences in gelation ability (Krasaekoopt et al., 
2003). This challenge formed the basis of our hypothesis that the higher biopolymer level used in 
this study would decrease pore size so as to form a more core protective capsule. Second, genipin 
induced protein crosslinking requires longer stir times and greater control over environmental 
conditions (e.g., pH and temperature) than required in an ionic gelation process, which is 
commonly employed for polysaccharide based wall materials. The longer stir time exposes the 
probiotics to non-ideal aerobic and mechanical shear conditions, possibly resulting in a loss of 
cell viability over the extended capsule formation time. Finally, proteins have a greater affinity to 
the water-oil interface than polysaccharides due to their surface characteristics (e.g., charge and 
hydrophobicity). A stronger affiliation to this interface negatively impacts capsule sedimentation 
and their subsequent harvest. 
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In the present study, B. adolescentis was encapsulated within the legume protein isolate 
wall materials (10% w/w; CPI, LPI, FPI and SPI) characterized in study 1, as discontinuous 
droplets within a continuous canola oil phase, which were then crosslinked by genipin to create 
covalent linkages to stabilize droplets into capsules. After 6 h of stirring at low speed (750 or 
1000 rpm), stirring ceased and 100 g of MQW was added to break the emulsion. Unfortunately, 
due to the high surface activity of the proteins (e.g., surface charge and hydrophobicity), 
separation into two distinct phases (oil and water) failed to occur, although instability of the 
emulsion was evident by the appearance of large coalescence droplets and the initial separation 
of layers. Photographs following MQW addition were taken for each legume protein isolate and 
are shown in Figure 4.7. All materials behaved similarly regardless of their surface charge 
(Figure 4.1) and hydrophobicity (Figure 4.2), however CPI and SPI based emulsions turned light 
blue (Figure 4.7A,C), whereas FPI and LPI based emulsions turned dark blue/purple (Figure 
4.7B,C). Differences in protein-stabilized emulsion colour upon genipin crosslinking may reflect 
differences in initial protein isolate colour, the degree of protein crosslinking, capsule porosity 
(impacting light scattering) or interactions with non-protein materials within the isolate itself 
(e.g., phenolics). A greater understanding of genipin-induced colour formation in these types of 
systems represents a future area of research that could be explored. 
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Figure 4.7  Photographs of genipin crosslinked CPI (A), FPI (B), LPI (C) and SPI (D) based 
emulsions following the addition of MQW to break the emulsion, but prior to 
centrifugation.  
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Because the genipin crosslinking reaction continues over time, leading to further 
aggregation of capsules; immediate harvesting was desired which required emulsion breakdown. 
To expedite emulsion instability, a centrifugation step was added (1000 x g for 5 min) to help 
facilitate emulsion breaking and to concentrate the formed capsules in the aqueous phase for 
harvest; this step was followed by the addition of 1.0% Tween 80 which facilitated capsule 
dispersion in the aqueous phase. Tween 80 (or polysorbate 80) has a hydrophilic-lipophilic 
balance (HLB) value of 15, and therefore has a greater affinity to hydrophobic phases (Kloet & 
Schramm, 2002). It was hypothesized that in an aqueous solution, Tween 80 would coat the 
surface of the protein capsules by interacting with hydrophobic amino acids, leaving hydrophilic 
groups accessible to create repulsion between neighbouring capsules so as to preserve them as 
discrete particles in solution. 
 
4.2.2.1 Enumeration of encapsulated Bifidobacterium adolescentis  
Once harvested, capsules were broken by vortexing at the highest setting for 30 s in order 
to determine by spread plating, the number of viable CFU mL-1 of encapsulated B. adolescentis. 
Although, homogenization under high shear is commonly used to break open capsule structures 
for enumeration of encapsulated probiotics at specific time points (Truelstrup-Hansen et al., 
2002; Wood, 2010); the vortexing method was more advantageous for these studies due to its 
ease of use, speed, lack of required cleaning between samples, and low sample volume 
requirement. These benefits became especially pertinent during acid challenge experiments as 
capsules were too small to be handled individually and so immediate neutralization of the entire 
aliquot of capsule solution removed at each time point was required. During a preliminary 
experiment, CPI capsules containing B. adolescentis were broken using both the vortexing and 
homogenization methods and gave similar (p>0.05) viable cell counts of 7.26 and 7.11 log CFU 
mL-1, respectively. 
In the present study, the encapsulation process (with the 1000 rpm stir speed) led to the 
entrapment of ~7.6, ~7.0, ~7.0 and ~5.6 log CFU mL-1 for CPI, FPI, LPI and SPI, respectively 
(Table 4.3), which represented a ~1-2.5 log CFU mL-1 reduction in viable numbers from initial 
growth. Although there were minor differences between encapsulation numbers, wall material 
type did not seem to play a significant role. However, the SPI based capsules were found to 
encapsulate the fewest CFU mL-1 relative to the other legume proteins. Based on these results, 
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and with the exception of SPI, probiotic encapsulation at these levels would only be sufficient to 
provide a health benefit (7.0 log CFU mL-1) in a 1 mL dose, if full survival and release of the 
organism was achieved. In study 1, the physicochemical properties of all legume proteins were 
relatively similar, with the exception of SPI solubility, which was significantly lower (p<0.05) 
(~50%) than the other legume proteins (~90%) (Figure 4.3). This lower solubility may have led 
to poor crosslinking of the SPI network within the droplet/capsule by genipin. The reduction of 
viable cell numbers as the result of the encapsulation process was thought to be due to: a) shear 
induced damage during mixing; b) prolonged exposure to aerobic conditions during the 6 h of 
crosslinking; and c) exposure to genipin and/or other compounds used in the encapsulation 
process (e.g., canola oil, Tween 80). Preliminary work (data not shown) indicated that Tween 80 
and genipin did not inhibit the growth or viability of B. adolescentis individually. However, this 
would not rule out the possibility of either compound playing a role in the reduction of viable 
cell numbers during the encapsulation process via a multi-hurdle mechanism of stress. Similar, 
although lower losses in probiotic viability during encapsulation processes were reported by 
Annan et al. (2008) with a ~0.8 log CFU mL-1 reduction for alginate coated gelatin-based 
microcapsules containing B. adolescentis, and by O’Riordan et al. (2001) with a ~0.78 log CFU 
mL-1 reduction for waxy maize starch-based capsules containing Bifidobacterium PL1. 
 
Table 4.3 Mean viable B. adolescentis (log CFU mL-1) initially encapsulated within genipin 
crosslinked legume protein microcapsules. Data represents the mean ± one 
standard deviation (n = 3). Data with the same superscript were not significantly 
different (p > 0.05). 
Sample log CFU mL-1 
Chickpea 7.64 ± 0.80a 
Faba bean 6.98 ± 0.16ab 
Lentil 7.01 ± 0.44ab 
Soy 5.63 ± 1.13b 
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4.2.3 Effect of stirring speed on the size of microcapsules produced by genipin induced 
crosslinking of legume protein isolates 
The effect of stir speed during the encapsulation process on capsule size was tested for 
each material in the absence of B. adolescentis. Capsule size was characterized by light 
scattering in terms of the volume weighted mean (VWM), the mode, and the size distribution of 
formed capsules. VWM is the average diameter of all particles analyzed within the scattering 
field, as determined by the volume they occupy, assuming spherical shape. Using the Mastersizer 
2000 instrument, capsule diameters can be separated into 100 size bins from 0.01 to 10,000 μm 
to give a size distribution curve. The size bin with the greatest percentile of particles is reported 
as the mode of capsule diameter. The VWM, mode and average percentile <100 µm for CPI, FPI, 
LPI and SPI based capsules formed with stir speeds of 750 and 1000 rpm  are shown in Table 
4.4. An analysis of variance was performed on: a) the VWM; b) the mode; and c) the percentage 
of capsules <100 μm so as to examine the effect of stir speed (750 vs. 1000 rpm), protein type 
(CPI, FPI, LPI and SPI) and their associated interaction. Statistical analysis of the data found 
only protein type (p<0.001) and the interaction of protein type with stir speed to be significant 
(p<0.001), whereas the effect of stir speed alone was insignificant (p>0.05). Based on the 
strength of the main effect (protein type), it was assumed that it weighted heavily on the degrees 
of freedom in the interaction term, and as such, the latter was neglected for discussion purposes. 
Overall, the VWM (independent of stir speed) capsules were found to have the greatest 
diameter when formed with SPI (~158 µm), followed by CPI (~133 µm), LPI (~127 µm) and FPI 
(~61 µm) (Table 4.4). Similarly, the mode of capsules followed a similar trend, decreasing in size 
in the following order: SPI (~145 µm), LPI (~122 µm), CPI (~98 µm) and FPI (~57 µm). In 
terms of percentages <100 µm, FPI had ~87% of its capsules below 100 µm, whereas CPI, LPI 
and SPI had ~52%, ~43% and ~32% below 100 μm respectively (Table 4.4). A Holm-Sidak post-
hoc pairwise multiple comparison indicated that for VWM only FPI was significantly different 
from the other three legume protein isolates (p<0.001), but considering both the mode of capsule 
size and percentage of capsules <100 µm, all legume protein types were significantly different 
from each other (p<0.05). The larger size of the SPI capsules relative to the other materials may 
be explained by the reduced solubility of SPI relative to the other legume proteins (Figure 4.3), 
which may have resulted in a less compact droplet. During crosslinking by genipin, the 
droplet/capsule network may not have been homogenous if the protein was not completely 
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soluble leading to larger average capsule sizes. However, solubility is only one factor impacting 
capsule size, as the other legume proteins have relatively similar solubility values, but differ 
widely in size. The size distribution for each material followed a very broad Gaussian-type 
distribution ranging in size from ~10 to 1000 µm (Figure 4.8). A wide size distribution is 
common for the emulsification process at relatively low stir speeds and long stirring duration (6 
h); but was most likely exacerbated by capsule aggregation caused by the formation of both short 
and long range (through polymerization of genipin molecules) crosslinking of proteins by 
genipin within and in-between droplets and by protein-protein interactions between droplets 
influenced by surface characteristics such as charge and hydrophobicity. Based on these findings, 
the 1000 rpm stir speed was chosen (arbitrarily) for further encapsulation studies. 
 
Table 4.4 Capsule size parameters (volume weighted mean, average mode, average 
percentile <100 µm) using chickpea (CPI), faba bean (FPI), lentil (LPI) and soy 
(SPI) protein isolate wall materials, at two different emulsification stir speeds. 
Data represents the mean ± one standard deviation (n=2). 
Sample Stir speed 
(rpm) 
Capsule size (μm) 
Volume weighted 
mean 
Average mode Average % 
<100 μm 
CPI 
750 106.70 ± 20.62 61.80 ± 16.91 59.78 ± 9.68 
1000 159.55 ± 62.41 135.29 ± 48.25 44.11 ± 16.88 
FPI 
750 70.10 ± 21.15 58.02 ± 10.30 82.58 ± 9.52 
1000 51.22 ± 3.18 56.37 ± 4.26 92.36 ± 2.87 
LPI 
750 124.79 ± 17.03 110.60 ± 16.29 48.75 ± 4.97 
1000 128.43 ± 18.67 133.36 ± 22.14 37.73 ± 8.22 
SPI 
750 189.98 ± 36.65 178.76 ± 73.47 22.94 ± 10.33 
1000 125.32 ± 6.20 111.38 ± 14.90 41.28 3.89 
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Figure 4.8  Average percent particle size distribution of legume protein capsules produced by 
emulsions employing stir speeds of 750 and 1000 rpm (n = 2). 
 
Caution should be taken when interpreting the size data (despite being statistically 
significant) due to the large standard deviations for CPI and SPI (Table 4.4) and challenges 
associated with light scattering particle size analysis. During light scattering, particles are fitted 
to an imaginary sphere, and then averaged over all of the particles within the scattering field. If 
aggregation occurs within the system, the larger structures will skew the averages (due to their 
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much greater volume) and reduce the accuracy of a spherical particle shape assumption, leading 
to an overestimation of the true size. Mie theory is used by the Mastersizer software to measure 
particle size in solution by light scattering. Mie theory was developed in 1908 by the German 
scientist Gustav Mie, and represents the ideal scattering of electromagnetic radiation (light) by an 
isotropic spherical particle (Mie, 1908; & Garcia-Rubio, 1992). This theory is now commonly 
used to determine particle size based on light scattering under the assumption of spherical shape 
(Garcia-Rubio, 1992; Scholz et al., 1998; Jones, 1999). It also considers that the solvent used to 
suspend particles refracts light, in addition to suspending the macromolecules, to form an 
optically heterogeneous system (Garcia-Rubio, 1992). As this method relies on scattering 
patterns as light interacts with particles in solution, the refractive index of both the solvent and 
the particle of interest are important in particle size determination (Garcia-Rubio, 1992). The 
Mastersizer 2000 software has default refractive index values for a variety of compounds and 
solvents including protein (1.45) and water (1.33). Other authors have used similar refractive 
index values for water (Michalski et al., 2001) and proteins (Neto et al., 2009). However, in this 
case, if some canola oil remained in the capsule solution post-harvest it could alter the refractive 
index of the solvent (water) suspending the capsules to introduce error and high standard 
deviations to this particle size analysis. The presence of neighbouring particles can also impact 
the scatter patterns of light as it interacts with a particle (Garcia-Rubio, 1992), making capsule 
dispersion vs. aggregation an important factor. Furthermore, biopolymers (including proteins) are 
weak point scatterers, meaning the signal measured in the instrument is relatively low (e.g., 
compared to a contaminating oil droplet). In the present study, both CPI and SPI produced light 
blue emulsions/capsules, whereas FPI and LPI produced dark blue/purple emulsions/capsules. 
Slight differences in capsule hue may also impact scattering intensities measured and in some 
cases cause high standard deviations. Overall this method of size analysis produced high 
standard deviations, and did not agree with the direct observation of particle size (Section 4.2.5). 
 
4.2.4 Acid challenge studies for free and encapsulated Bifidobacterium adolescentis 
Genipin crosslinked CPI, LPI, FPI and SPI capsules with encapsulated B. adolescentis 
were subjected to an acid challenge study at pH 2.0 for 2 h, and then compared to the survival of 
free cells (Figure 4.9). In all cases (regardless of wall material), significant cell death occurred 
immediately, and after 30 min no viable cells could be detected (detection limit of 3.0 log CFU 
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mL
-1
). Free cells followed a similar profile, except initial viable counts were higher (Figure 4.9) 
as free cells did not experience the ~1-2.5 log CFU mL
-1
 decrease associated with encapsulation. 
Since the encapsulation procedure was lengthy, preliminary experiments were performed to test 
whether the procedure was pre-stressing the bacteria prior to entering the acid challenge, in 
addition to reducing the total numbers. During these experiments cells were added after 3 and 5 h 
of stirring to reduce probiotic exposure time to 3 and 1 h respectively. However, cells fared even 
worse in the acid challenge than those encapsulated over the full 6 h, most likely due to the 
proteins having already started to form their network, leaving the majority of probiotics to be 
non-encapsulated or located on, or near the surface of the capsule. Originally, it was 
hypothesized that capsules prepared using globular proteins may form a more dense wall with 
smaller pore sizes than those observed in polysaccharide-based designs. This was based on the 
utilization of a higher wall material concentration (10% w/v), and the use of genipin to induce 
intra- and inter-molecular protein-protein covalent crosslinking within the capsule (Butler et al., 
2003), in order to create a strong and probiotic-protective wall structure. Unfortunately, 
experimental results from this study did not support this hypothesis. Capsule formulations 
employed in this study did not offset the high surface area-to-volume ratio of the small capsules 
produced. Sultana et al. (2000) reported that such ratios enable greater interactions with the 
surrounding environment (acid) and poor probiotic survival.  
Other emulsion-based capsules with polymeric wall materials (e.g., alginate, alginate-
starch) have been shown to protect probiotics in a food matrix (milk, yogurt, etc.), but not in 
simulated gastric juice at sizes <1 mm (Sultana et al., 2000; Truelstrup-Hansen et al., 2002). For 
example, Sultana et al. (2000) utilized a 2% alginate, 2% Hi-maze resistant starch wall material, 
hardened with the addition of 0.1 M CaCl2 to encapsulate Lactobacillus acidophilus and 
Bifidobacterium species. Capsules were mainly 0.5 – 1.0 mm in size, however a small proportion 
were found to be < 500 μm. When exposed to pH 2.0 for 3 h, a 5 log CFU mL-1 and a 3 log CFU 
mL
-1
 reduction from initial numbers of ~11.6 log CFU mL
-1
 were found for L. acidophilus and B. 
infantis, respectively. Smaller capsules were reported to have even less acid tolerance by 
Truelstrup-Hansen et al. (2002) who produced Ca
2+
-alginate capsules (20 g L
-1
 alginate, 5 g L
-1
 
Tween 80, 62.5 mM CaCl2) containing four strains of Bifidobacterium at levels ranging from 6-8 
log CFU mL
-1
, with an average size of 70 μm, using emulsion technology. When exposed to pH 
2.0, a 5 log CFU mL
-1
 reduction in cell numbers occurred after only 30 min for all strains except 
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B. lactis, which remained constant. In contrast, Borza et al. (2010) reported that an emulsion-
based method produced gelatin (16%)-maltodextrin (3%) composite microcapsules crosslinked 
with genipin (24 mM), having a size of ~70 μm, which were able to protect encapsulated B. 
adolescentis from SGJ (pH 2.0; 0.32 mg mL
-1
 pepsin). After 2 h of exposure to SGJ free cells 
experienced a ~4 log CFU mL
-1
 reduction in numbers while encapsulated cells experienced only 
a ~2 log CFU mL
-1
 reduction. 
 
4.2.5 Effect of biopolymer coatings and/or prebiotics on CPI encapsulated 
Bifidobacterium adolescentis survival in acid challenge experiments 
The effect of coating materials (chitosan and napin) and/or the addition of the prebiotic, 
fructooligosaccharides (FOS) were investigated as a means for improving the survival of B. 
adolescentis employing a genipin crosslinked CPI-based capsule during an acid challenge. Only 
CPI capsules were used in this research as experimental data indicated that all of the legume 
protein isolates behaved relatively similar in terms of probiotic protection (Figure 4.9). Also, 
research results showed that CPI displayed the highest initial viable counts after encapsulation 
(~7.6 log CFU mL
-1
) than the other materials (Table 4.4). Based on zeta potential data from 
study 1, CPI carries a negative charge at pH 7.0 (-47.7 mV, Figure 4.1) and therefore is capable 
of electrostatically coupling to cationic coating materials such as napin and chitosan 
(Wanasundara, 2011; Peng et al., 2012). Capsules containing an outer napin/chitosan coat are 
hypothesized to increase the survival of encapsulated B. adolescentis during the acid challenge 
experiment. The prebiotic FOS was also added to capsules in the presence of coatings as it has 
been demonstrated to be beneficial to the survival of several strains of B. adolescentis (Gibson & 
Wang, 1994; Rossi et al., 2005; Wood, 2010). Prebiotics function to benefit probiotics by 
selectively stimulating their growth and/or activity (Gibson & Wang, 1994b; Crittenden, 2001), 
and therefore while FOS may benefit probiotics through the encapsulation process, no increase in 
acid protection was hypothesized. 
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Figure 4.9  Survival of B. adolescentis (log CFU mL
-1
) in genipin crosslinked legume protein 
isolate microcapsules exposed to an acid challenge (pH 2.0) as compared to free 
cells. Data represent the mean ± one standard deviation (n=3). 
 
In the present study, the addition of coatings and/or FOS did not significantly reduce cell 
viability during encapsulation relative to the control (CPI without coatings or FOS) (p>0.05), 
with the exception of the chitosan coating without FOS, where viability was significantly 
reduced from ~7.6 to ~6.0 log CFU mL
-1
 (p<0.05; Table 4.5). Chitosan has known antimicrobial 
properties and several mechanisms have been proposed for this effect including ionic interaction 
with cell membranes to alter permeability and chelation of ions leading to cell toxicity. The 
antimicrobial properties of chitosan also appear to be related to both molecular weight and 
degree of polymerization (Kim et al., 1997; Chen et al., 1998; Rabea et al., 2003). Formulation 
of chitosan-coated CPI capsules with FOS seemed to mediate the impact of the antimicrobial 
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effects of chitosan, as survival was statistically similar to the control, (p>0.05). Overall, no 
additional protective effect was observed with the addition of chitosan coatings with or without 
FOS (Figure 4.10). During acid challenge, napin-coated CPI capsules with and without FOS 
seemed to show enhanced survival relative to the control, however the protective effect was not 
enough to impart a beneficial impact to human health, still showing a ~3 log CFU mL
-1
 reduction 
within the first 30 min of acid exposure (Figure 4.11). No differences were observed between 
napin-coated CPI capsules with and without FOS. However, napin coated CPI capsules were 
able to maintain viable probiotics at 3.97 log CFU mL
-1
 with FOS addition (3.85 CFU mL
-1
 
without FOS) after 2 h of acid exposure, which is noteworthy because although the minimum 
resolution for enumeration by the plate count method in these experiments was 3.00 log CFU 
mL
-1
, the trend of rapid cell death (even after only 30 min) in all other cell formulations suggests 
there was no survival through the acid challenge. Furthermore, this acid challenge may be 
unnecessarily restrictive to microbial survival as other simulated gastric juice models often 
utilize variable pH values (~2 – 5) over the course of a 2 h stomach transit time to better reflect 
in vivo stomach conditions as a meal is digested (Marteau et al., 1997; Lee & Heo, 2000). 
Therefore, there is potential for even greater performance of this capsule formulation, which 
already shows improvement by protecting nearly 4.0 log CFU mL
-1
 (Figure 4.10) compared to 
presumed complete death in all other capsule formulations. As such, the use of a more moderate 
SGJ/SIF model, where capsules are incorporated into a food matrix may merit future 
investigation. 
Polymer coatings have previously been shown to increase encapsulated probiotic survival 
in literature. For example, Annan et al. (2008) found that gelatin-based (13% w/v) capsules, 
crosslinked with genipin (1.25 mM) and coated with alginate, having average sizes of ~50 μm 
were able to protect encapsulated B. adolescentis 15703T from both SGJ (pH 2.0; 0.2% NaCl; 
0.3g L
-1
 pepsin) and sequential exposure to SGJ and SIF (pH 7.4; 1 g L
-1
 pancreatin; 4.5 g L
-1
 
bile salts) better than uncoated capsules and free cells. After 2 h exposure to SGJ a 1.21, 2.55 and 
3.45 log CFU mL
-1
 reduction was reported for encapsulated cells with an alginate coating, 
encapsulated without a coating, and free cells, respectively. After sequential exposure to SGJ    
(1 h) and SIF (4 h), ~7.6 log CFU mL
-1
 remained within the coated microcapsules compared to 
~6.7 and ~6.4 log CFU mL
-1
 for encapsulated without coating, and free cells, respectively. In 
addition, Iyer et al. (2005) reported that chitosan-coated alginate-starch capsules containing L. 
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casei strain Shirota were able to protect the probiotic through ex vivo porcine gastro-intestinal 
contents for release at levels of ~ 8 log CFU mL
-1
 in ileum and colon fluids after 4 and 8 h 
incubations respectively. 
 
 
 
 
Table 4.5  Mean viable B. adolescentis (log CFU mL
-1
) initially encapsulated in genipin 
crosslinked chickpea protein microcapsules with and without chitosan and napin 
coatings and fructooligosaccharides (FOS) addition. Data represent the mean ± 
one standard deviation (n = 3). Data with the same superscript is not significantly 
different (p>0.05). 
 
Sample log CFU mL
-1
 
CPI (control: uncoated and without FOS) 7.64 ± 0.80
a
 
CPI capsules with FOS (uncoated) 7.25 ±0.24
a
 
Chitosan-coated CPI capsules 6.04 ± 0.39
b
 
Chitosan-coated CPI capsules with FOS 7.16 ± 0.12
a
 
Napin-coated CPI capsules 7.80 ± 0.06
a
 
Napin-coated CPI capsules with FOS 7.84 ± 0.03
a
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Figure 4.10 The impact of fructooligosaccharides, and chitosan and napin coatings to genipin 
crosslinked CPI capsules on the survival of encapsulated B. adolescentis (log 
CFU mL
-1
) during an acid challenge (pH 2.0). Data represent the mean ± one 
standard deviation (n=3). 
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4.2.6 Imaging of chickpea protein capsules 
Microscopy was utilized to analyze: a) the size and shape of genipin crosslinked CPI 
capsules with and without a napin coating; and b) the distribution of B. adolescentis throughout 
the capsule matrix (using the SYTO®-9 fluorescent tag) with a napin coating. Representative 
images taken at 400x magnification for genipin crosslinked CPI capsules in the absence and 
presence of a napin coating are shown in Figure 4.11. In all cases, capsules appeared spherical in 
shape and were present as individual and/or flocculated aggregates. Flocculation of capsules may 
have been the result of genipin crosslinking or associations driven by hydrophobic interactions 
between proteins on adjacent capsules. ImageJ particle sizing software was used to analyze 
digitized images from multiple fields of view (n = 5, with 138-254 capsules per field) to 
determine the average diameters of 5.35 ± 0.30 μm and 4.83 ± 0.99 μm for CPI capsules in the 
absence and presence of a napin coating, respectively. No statistical differences were found with 
the addition of the napin coating (p>0.05). The size of the formed CPI capsules with and without 
a napin coating was approximately ~20-25 times smaller (~5 µm in diameter) than the data 
estimated by light scattering (Table 4.3). The larger sizes estimated by light scattering may 
reflect the instruments inability to distinguish differences between protein-protein aggregates 
(non-capsule particles), flocculated capsules and individual capsules as the technique assumes 
that all particles are point scatters. Furthermore, protein matrices are only weakly scattering 
particles (e.g., higher noise-to-signal ratio). While light microscopy digital images enabled 
visualization of the very small CPI capsules produced, undertaking particle size determination 
using this method may have some bias against large sized particles resulting in lower average 
size results. Large capsules can be difficult to clearly picture using microscopy and may not 
appear if they are too thick for sufficient light to penetrate. Regardless, the capsules observed via 
microscopy were significantly smaller than indicated by light scattering, which may explain their 
lack of acid protection given their high and detrimental surface area to volume ratios. 
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        A      B 
 
Figure 4.11  Light microscopy digital image of CPI capsules (with encapsulated B. 
adolescentis) in the absence (A) and presence (B) of a napin coating under 400x 
magnification. Arrows depict areas of capsule aggregation.  
 
Fluorescence microscopy indicated that B. adolescentis were present in small as well as 
larger capsules and in the capsule solution, as indicated by areas of brightened fluorescence 
(Figures 4.12, 4.13), and that some capsules, or capsule aggregates, were produced near the 
desired 100 µm size. The SYTO®-9 fluorescent tag is a membrane penetrative green fluorescent 
nucleic acid dye, capable of staining live, viable cells that results in fluorescence under UV 
exposure allowing for bacterial visualization. Figure 4.12-A/B show the same very large (~200 
μm) capsule at two layers of focus, containing a large number of encapsulated B. adolescentis, 
depicted by bright fluorescent points. Although not the normal arrangement, the thicker capsule 
wall and smaller surface area to volume ratio of capsules of this type/size may be responsible for 
a large proportion of exhibited probiotic protection (e.g., 3.97 log CFU mL
-1
; Figure 4.10) from 
the previous experiment. The more common, small and dispersed capsule arrangement within the 
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solution as depicted in Figure 4.12-C likely offered very little acid protection due to the higher 
exposure to the environment. The apparent probiotic distribution, throughout the capsules, is 
most likely the result of vigorous stirring during emulsion formation. Figure 4.13 depicts the 
same large capsule as Figure 4.12, although at a higher magnification and at three levels of 
focus. Chains of brightened bacteria can be visualized (Figure 4.13-B/C: white arrows), which is 
the normal growth arrangement for B. adolescentis (Gibson & Roberfroid, 1995). The large 
undefined areas of brightened fluorescence (Figure 4.13-A: black arrow) are presumed to be 
other B. adolescentis on different capsule layers, which are out of focus, as this image depicts a 
large capsule in 3D. The probiotic protection demonstrated in Section 4.2.4 may have been a 
result of a small number of capsules of a size near or above 100 μm, which as a result had a 
thicker capsule wall and a more moderate surface area to volume area ratio allowing them to 
protect B. adolescentis throughout the acid challenge, whereas the individual/dispersed, smaller 
(e.g., ~5 μm) capsules likely provided little to no acid protection. 
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Figure 4.12 Fluorescent microscopy digital images at 160x magnification of a CPI capsule 
solution demonstrating: large capsule focal plane 1 (A), large capsule focal plane 
2 (B), solution background with smaller capsules and free bacteria (C) showing 
common capsule size and probiotic distribution and stage micrometer (D). 
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Figure 4.13 Fluorescent microscopy images at 1000x magnification of a CPI capsule solution 
demonstrating a view of three focal points (A, B and C) of single large capsule 
with encapsulated bacteria and a stage micrometer view for scale (D). White 
arrows indicate chains of B. adolescentis cells in focus, and the black arrow 
indicates brightened fluorescence of unfocused cells. 
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5 CONCLUSIONS 
 
Select physicochemical properties of four legume protein isolates and their crosslinking 
affinity with genipin were evaluated in terms of their emulsifying properties and potential to act 
as a wall material for probiotic encapsulation. Overall, legume protein isolates were able to act as 
emulsifiers due to their amphiphilic nature so as to stabilize Millipore Milli-Q
TM
 produced water 
(MQW)-canola oil emulsions, which was enhanced in the presence of genipin. However, a full 
understanding of the impact of the protein isolate’s physicochemical properties on emulsion 
stability was difficult, reflecting the complexity of the system. To be an effective emulsifier, the 
protein needs to have sufficient surface charge to remain water soluble such that it can migrate to 
the oil-water interface, and have enough surface hydrophobicity to align and re-orient once there 
(Schwenke, 2001; Damodaran, 2005). Based on these criteria, it would have been presumed that 
chickpea protein isolate (CPI) would give the best emulsion stability based on its high solubility 
and surface hydrophobicity relative to the other protein isolates. However, CPI displayed the 
lowest stability of all of the four legume protein isolates examined. To better understand the 
structure-function mechanisms in legume protein isolate stabilized emulsions, further studies on 
the role of protein characteristics (e.g., conformation, concentration and level of denaturation), 
solvent effects (e.g., pH, temperature, salts), processing factors (e.g., homogenization rates and 
duration) and emulsion characteristics (e.g., oil-water ratio, droplet size) are needed. 
Encapsulation of B. adolescentis within legume protein capsules, crosslinked by genipin 
was achieved with viable cell numbers of ~7.21 log colony forming units (CFU) mL
-1
; however 
this did not translate into a protective effect during an acid challenge. Furthermore, there was 
disagreement between capsule size as determined by microscopy imaging and light scattering 
due in part to the presence of aggregates in solution. However, CPI capsules demonstrated an 
ability to encapsulate the greatest number of B. adolescentis and so were utilized to investigate 
strategies for improving capsule formulation performance. CPI capsules coated with napin 
protein showed improved survival, however the improvement was only minor; still providing 
insufficient capabilities as a product. Although microscopy indicated that the capsules produced 
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by this method were significantly smaller than anticipated, probiotics were found to be 
distributed throughout capsules. In addition, a small proportion of larger capsules (near or above 
100 μm in size) were identified and hypothesized to be responsible for the acid protection that 
was experienced by the napin coated capsules as a factor of their more moderate surface area to 
volume ratios. Although this study did not achieve the end goal of encapsulated probiotic 
survival levels of 7.0 log CFU mL
-1
 novel information of this subject was generated for 
emulsion-based genipin crosslinked, legume protein encapsulation. 
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6 FUTURE STUDIES 
 
The current research investigated the relationship between the physicochemical 
properties of legume protein isolates and their ability to act as emulsifiers with and without 
genipin-induced crosslinking, and as encapsulating agents for probiotic delivery. However, to 
better understand the structure-function mechanisms in legume protein-stabilized emulsions, 
further studies on the role of protein characteristics (e.g., conformation, concentration and level 
of denaturation), solvent effects (e.g., pH, temperature, salts), processing factors (e.g., 
homogenization rates and duration) and emulsion characteristics (e.g., oil-water ratio, droplet 
size) are needed. Furthermore, investigation of crosslinking conditions surrounding protein 
reactions with genipin is needed in order to optimize crosslinking concentration, temperature and 
time.  
Although some acid protection to the probiotics was afforded by the final napin-coated 
capsule design, survival levels still remained well below what is needed to offer a beneficial 
impact to a host. Better control over capsule size, as determined by stir speed, protein 
concentration, wall-to-core ratio and crosslinking conditions could result in improved/better 
controlled capsule size and protection to encapsulated probiotics. Manipulating these conditions 
could also lead to greater control over the pore size of the wall material, where smaller pores 
may lead to enhanced survival. Differences in pore size among different wall 
formations/conditions could be assessed using scanning electron microscopy. Possibly, the 
replacement of genipin with other non-toxic fixatives such as transglutaminase, or using protein-
polysaccharide composite materials with ionic fixatives might reduce encapsulation time further, 
leading to increased control over capsule size. 
If a capsule formulation was developed with adequate acid protection capabilities, 
investigation into performance in a system more closely related to the human gastrointestinal 
tract (GIT) would be necessary. This research did not investigate capsule release of probiotics, 
which is an essential function of a probiotic delivery system. Sequential exposure to simulated 
gastric juice (SGJ) and simulated intestinal fluid (SIF) and/or the use of a simulation of the
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human intestinal microbial environment (SHIME) system could provide a better benchmark of 
capsule performance. The use of an animal model could also provide information on capsule 
performance in addition to evaluating potential to market capsules for animal feed additives in 
addition to a human food ingredient. Finally incorporation of capsules into a food matrix or as a 
food additive, with or without freeze drying, and evaluation of survival, shelf stability and 
subsequent capsule performance are also necessary investigations prior to marketing probiotic 
containing capsules of this nature as a human health supplement. 
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